<html>
<head>
<META HTTP-EQUIV='Content-Type' CONTENT='text/html; charset=big5'>
<?xml version="1.0" encoding="UTF-8"?> 
<html xmlns="http://www.w3.org/1999/xhtml"
xmlns:ifrs-full="http://xbrl.ifrs.org/taxonomy/2017-03-09/ifrs-full"
xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
xmlns:link="http://www.xbrl.org/2003/linkbase"
xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
xmlns:xbrli="http://www.xbrl.org/2003/instance"
xmlns:xlink="http://www.w3.org/1999/xlink"
xmlns:ix="http://www.xbrl.org/2013/inlineXBRL"
xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26"
xmlns:tifrs-SCF="http://www.xbrl.org/tifrs/scf/2020-06-30"
xmlns:tifrs-ar="http://www.xbrl.org/tifrs/ar/2020-06-30"
xmlns:tifrs-bsci-ci="http://www.xbrl.org/tifrs/bsci/ci/2020-06-30"
xmlns:tifrs-es="http://www.xbrl.org/tifrs/es/2020-06-30"
xmlns:tifrs-notes="http://www.xbrl.org/tifrs/notes/2020-06-30">
<head> 
	<meta http-equiv="Content-Type" content="text/html; charset=utf-8" /> 
	<title> 6499 2022Q4 Financial report</title> 
	<script src="https://code.jquery.com/jquery-3.2.1.min.js" type="text/javascript"></script> 
	<script type="text/javascript"> 
		/*<![CDATA[*/ 
		function showChineseReport() { 
			$(".zh").show();
			$(".en").hide();
		}
		function showEnglishReport() {
			$(".en").show();
			$(".zh").hide();
		}
		$(document).ready(function() { 
			if (location.search.indexOf("?") != -1 && 
			location.search.split("?")[1].split("=")[1] == "en") 
				showEnglishReport(); 
			else 
				showChineseReport(); 
		});	
		/*]]>*/ 
	</script> 
	<style type="text/css"> 
		body,html {height: 100%;} 
		body {font-size: 15px;font-family: Arial;color: #000;background: #4E5869;margin: 0;padding: 0;background-color: #FFF;} 
		td,th {border: 1px solid #dddddd;padding: 5px;color: #333;background-color: #FFF;} 
		th#t1 {color: #165c98 !important;} 
		ul,ol,dl {padding: 0;margin: 0;} 
		h3 {color: #165c98;font-size: 18px;} 
		pre {font-size: 15px;font-family: Arial;} 
		.container {width: 100%;background: #FFF;margin: 0 auto;background-color: #999;} 
		.header {text-align: center;background: #165c98;margin-right: auto;color: #fff;} 
		.header > div:first-of-type {position: absolute;right: 15px;top: 15px;} 
		.header > div:nth-of-type(2) {font-size: 25px;text-align: center;line-height: 35px;} 
		.header a {text-decoration: none;margin:0 10px;color: #ffffff;} 
		.nav {float: left;width: 200px;height: calc(100% - 85px);overflow: auto;background: #fff;padding-bottom: 15px;} 
		.nav > div {padding: 10px;color: #165c98;font-size: 20px;font-weight: bold;} 
		.nav > ul {list-style: none;border-top: 1px solid #666;margin-bottom: 15px;} 
		.nav > ul li{border-bottom: 1px solid #666;} 
		.nav > ul a{padding: 5px 2px 5px 10px;display: block;text-decoration: none;background: #fff;color: #333;} 
		.nav > ul a:hover{background: #165c98;color: #fff;} 
		.content {width: calc(100% - 200px);height: calc(100% - 70px); float: left;background: #efefef;overflow: auto;} 
		.content > div[id*="link"] {height: 15px;} 
		.content table {border-collapse: collapse;margin: 0 20px;} 
		.content ul, 
		.content ol {padding: 15px 10px 10px 15px;} 
		.content table tr th {background: #7fcef5;color: #165c98;} 
		.content table tr:first-child th {background: #165c98;color: #fff;font-size: 15px;text-align: left;} 
		.content table tr:nth-of-type(odd) > td {background-color: #d3edfa;} 
		.title {font-size: 18px;font-weight: bold;margin-left: 20px;} 
		.rptidx {color: #000;margin-left: 20px;} 
		.amt {text-align: right} 
		.note {font-family: 細明體} 
		@media print{ 
			.header a{display: none;} 
			.nav{display: none;} 
			.content{width: 100%;height:auto;float: inherit;overflow: inherit;background: #fff!important;} 
			.content table{width: 100%!important;margin: 0;} 
			body{color: #000;} 
			td,th{color: #000;border: 1px solid #000;} 
		} 
	</style> 
</head> 
<body> 
	<div style="display:none"> 
		<ix:header> 
			<ix:hidden> 
				<ix:nonNumeric name="tifrs-notes:CompanyID" contextRef="From20220101To20221231">6499</ix:nonNumeric> 
				<ix:nonNumeric name="tifrs-notes:CompanyChineseName" contextRef="From20220101To20221231">益安生醫股份有限公司</ix:nonNumeric> 
				<ix:nonNumeric name="tifrs-notes:CompanyEnglishName" contextRef="From20220101To20221231">Medeon Biodesign, Inc.</ix:nonNumeric> 
				<ix:nonNumeric name="tifrs-notes:Year" contextRef="From20220101To20221231">2022</ix:nonNumeric> 
				<ix:nonNumeric name="tifrs-notes:Quarter" contextRef="From20220101To20221231">4</ix:nonNumeric> 
				<ix:nonNumeric name="tifrs-notes:ReportType" contextRef="From20220101To20221231">Financial report (general)</ix:nonNumeric> 
				<ix:nonNumeric name="tifrs-notes:ReportCategory" contextRef="From20220101To20221231">Consolidated report</ix:nonNumeric> 
				<ix:nonNumeric name="tifrs-notes:Market" contextRef="From20220101To20221231">Over-the-counter</ix:nonNumeric> 
				<ix:nonNumeric name="tifrs-notes:IndustrySector" contextRef="From20220101To20221231">Commercial and industrial</ix:nonNumeric> 
			</ix:hidden> 
			<ix:references>
				<link:schemaRef xlink:href="tifrs-ci-cr-2020-06-30.xsd" xlink:type="simple"/>
			</ix:references>
			<ix:resources> 
				<xbrli:context id="From20210101To20210101_SpecialReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SpecialReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20211231_EquityAttributableToOwnersOfParentMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_IssuedCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_ReserveOfCashFlowHedgesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfCashFlowHedgesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_SecurityTokenOffer"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SecurityTokenOffer</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_SpecialReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SpecialReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20210101_ReserveOfExchangeDifferencesOnTranslationMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20210101_PreferenceShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:PreferenceShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20211231To20211231_EquityAttributableToOwnersOfParentMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-12-31</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20211231_AdvanceReceiptsForShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:AdvanceReceiptsForShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20210101_EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_StockDividendToBeDistributedMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:StockDividendToBeDistributedMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20211231To20211231_EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-12-31</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20210101_ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20211231_SpecialReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SpecialReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20210101_ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_RetainedEarningsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20211231"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20211231_PreferenceShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:PreferenceShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20211231_OrdinaryShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:OrdinaryShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_GainsLossesOnHedgingInstrumentsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnHedgingInstrumentsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_ReserveOfOverlayApproachMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfOverlayApproachMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20210101_Total3"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="tifrs-notes:MovementOnAllowanceForDoubtfulAccountsAbstractMemberDimensionMember">tifrs-notes:Total3</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_ReserveOfCashFlowHedgesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfCashFlowHedgesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_EquityAttributableToOwnersOfParentMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_StockDividendToBeDistributedMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:StockDividendToBeDistributedMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_AdvanceReceiptsForShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:AdvanceReceiptsForShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_TotalEquityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:TotalEquityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_ReserveOfRemeasurementsOfDefinedBenefitPlansMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20210101_EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20211231To20211231_ReserveOfRemeasurementsOfDefinedBenefitPlansMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-12-31</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20210101_ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20210101_StatutoryReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:StatutoryReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20211231_AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20211231To20211231_GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-12-31</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_CapitalReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20211231_StockDividendToBeDistributedMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:StockDividendToBeDistributedMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_NoncontrollingInterestsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_StatutoryReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:StatutoryReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20211231_IssuedCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20211231_EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_EquityAttributableToOwnersOfParentMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_RetainedEarningsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20210101_CertificateOfEntitlementToNewSharesFromConvertibleBondMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:CertificateOfEntitlementToNewSharesFromConvertibleBondMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_SpecialReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SpecialReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20211231_GainsLossesOnHedgingInstrumentsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnHedgingInstrumentsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20211231_AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_RevaluationSurplusMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RevaluationSurplusMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20210101_StatutoryReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:StatutoryReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_TreasurySharesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20210101_RetainedEarningsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_CertificateOfEntitlementToNewSharesFromConvertibleBondMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:CertificateOfEntitlementToNewSharesFromConvertibleBondMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20211231_RetainedEarningsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20210101_EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_ReserveOfRemeasurementsOfDefinedBenefitPlansMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_Others-OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Others-OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20211231_CapitalReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20210101_ReserveOfRemeasurementsOfDefinedBenefitPlansMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20211231To20211231_StatutoryReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-12-31</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:StatutoryReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_ReserveOfRemeasurementsOfDefinedBenefitPlansMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20211231To20211231_OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-12-31</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20211231To20211231_StockDividendToBeDistributedMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-12-31</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:StockDividendToBeDistributedMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20210101_ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_GainsLossesOnHedgingInstrumentsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnHedgingInstrumentsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20210101_AdvanceReceiptsForShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:AdvanceReceiptsForShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20211231_NoncontrollingInterestsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20210101_RetainedEarningsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_UnappropriatedRetainedEarningsAccumulatedDeficitMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:UnappropriatedRetainedEarningsAccumulatedDeficitMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_StockDividendToBeDistributedMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:StockDividendToBeDistributedMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_ReserveOfOverlayApproachMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfOverlayApproachMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20211231_RetainedEarningsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20211231To20211231_SpecialReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-12-31</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SpecialReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20211231_RevaluationSurplusMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RevaluationSurplusMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20210101_TreasurySharesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20211231_EquityAttributableToOwnersOfParentMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20211231_IssuedCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_AdvanceReceiptsForShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:AdvanceReceiptsForShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_PreferenceShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:PreferenceShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_ReserveOfExchangeDifferencesOnTranslationMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20210101_ReserveOfExchangeDifferencesOnTranslationMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_TreasurySharesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20210101_StockDividendToBeDistributedMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:StockDividendToBeDistributedMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20211231To20211231_RetainedEarningsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-12-31</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_Others-OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Others-OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_SpecialReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SpecialReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_Total3"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="tifrs-notes:MovementOnAllowanceForDoubtfulAccountsAbstractMemberDimensionMember">tifrs-notes:Total3</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20211231_CertificateOfEntitlementToNewSharesFromConvertibleBondMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:CertificateOfEntitlementToNewSharesFromConvertibleBondMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_StatutoryReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:StatutoryReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20211231_TreasurySharesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_RevaluationSurplusMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RevaluationSurplusMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_CertificateOfEntitlementToNewSharesFromConvertibleBondMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:CertificateOfEntitlementToNewSharesFromConvertibleBondMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_GainsLossesOnHedgingInstrumentsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnHedgingInstrumentsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_StatutoryReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:StatutoryReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_RevaluationSurplusMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RevaluationSurplusMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_ReserveOfCashFlowHedgesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfCashFlowHedgesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20210101_RevaluationSurplusMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RevaluationSurplusMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20210101_SpecialReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SpecialReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_ReserveOfExchangeDifferencesOnTranslationMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_ReserveOfOverlayApproachMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfOverlayApproachMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20211231_RevaluationSurplusMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RevaluationSurplusMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_ReserveOfRemeasurementsOfDefinedBenefitPlansMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20210101_EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20210101_Other-ShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Other-ShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20211231_ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20211231_ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20211231_AdvanceReceiptsForShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:AdvanceReceiptsForShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_UnappropriatedRetainedEarningsAccumulatedDeficitMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:UnappropriatedRetainedEarningsAccumulatedDeficitMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_Total3"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="tifrs-notes:MovementOnAllowanceForDoubtfulAccountsAbstractMemberDimensionMember">tifrs-notes:Total3</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_GainsLossesOnHedgingInstrumentsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnHedgingInstrumentsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20210101_ReserveOfOverlayApproachMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfOverlayApproachMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_RetainedEarningsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20210101_ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_PreferenceShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:PreferenceShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_EquityAttributableToOwnersOfParentMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20211231_SecurityTokenOffer"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SecurityTokenOffer</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20210101_Others-OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Others-OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20211231_ReserveOfExchangeDifferencesOnTranslationMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20211231_ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20211231To20211231_Others-OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-12-31</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Others-OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20210101_OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20211231_ReserveOfCashFlowHedgesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfCashFlowHedgesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_StatutoryReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:StatutoryReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_CapitalReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20211231_ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20210101_StockDividendToBeDistributedMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:StockDividendToBeDistributedMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20211231To20211231_ReserveOfExchangeDifferencesOnTranslationMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-12-31</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20211231_GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20211231To20211231_UnappropriatedRetainedEarningsAccumulatedDeficitMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-12-31</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:UnappropriatedRetainedEarningsAccumulatedDeficitMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230223"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-02-23</xbrli:instant> 
					</xbrli:period> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_ReserveOfRemeasurementsOfDefinedBenefitPlansMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20211231_StatutoryReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:StatutoryReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_TreasurySharesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20210101_PreferenceShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:PreferenceShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_PreferenceShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:PreferenceShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_CertificateOfEntitlementToNewSharesFromConvertibleBondMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:CertificateOfEntitlementToNewSharesFromConvertibleBondMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20210101_GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20211231_ReserveOfOverlayApproachMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfOverlayApproachMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20210101_OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20210101_Total3"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="tifrs-notes:MovementOnAllowanceForDoubtfulAccountsAbstractMemberDimensionMember">tifrs-notes:Total3</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20211231_UnappropriatedRetainedEarningsAccumulatedDeficitMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:UnappropriatedRetainedEarningsAccumulatedDeficitMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20210101_GainsLossesOnHedgingInstrumentsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnHedgingInstrumentsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20211231_PreferenceShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:PreferenceShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_Total3"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="tifrs-notes:MovementOnAllowanceForDoubtfulAccountsAbstractMemberDimensionMember">tifrs-notes:Total3</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20211231_Others-OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Others-OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20211231_StatutoryReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:StatutoryReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20211231To20211231_AdvanceReceiptsForShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-12-31</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:AdvanceReceiptsForShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20210101_CapitalReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20210101_AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20211231_UnappropriatedRetainedEarningsAccumulatedDeficitMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:UnappropriatedRetainedEarningsAccumulatedDeficitMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_TotalEquityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:TotalEquityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20211231To20211231_TreasurySharesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-12-31</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_UnappropriatedRetainedEarningsAccumulatedDeficitMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:UnappropriatedRetainedEarningsAccumulatedDeficitMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20211231To20211231_Other-ShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-12-31</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Other-ShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_CapitalReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20210101_TotalEquityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:TotalEquityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_NoncontrollingInterestsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20211231_EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20210101_SecurityTokenOffer"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SecurityTokenOffer</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20211231_CapitalReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_TreasurySharesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_Total3"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="tifrs-notes:MovementOnAllowanceForDoubtfulAccountsAbstractMemberDimensionMember">tifrs-notes:Total3</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_OrdinaryShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:OrdinaryShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20210101_CertificateOfEntitlementToNewSharesFromConvertibleBondMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:CertificateOfEntitlementToNewSharesFromConvertibleBondMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_RevaluationSurplusMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RevaluationSurplusMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_OrdinaryShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:OrdinaryShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_Other-ShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Other-ShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20211231To20211231_ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-12-31</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_RevaluationSurplusMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RevaluationSurplusMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20210101_TreasurySharesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_StockDividendToBeDistributedMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:StockDividendToBeDistributedMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20210101_AdvanceReceiptsForShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:AdvanceReceiptsForShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20210101_NoncontrollingInterestsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_OrdinaryShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:OrdinaryShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20210101_ReserveOfOverlayApproachMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfOverlayApproachMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_OrdinaryShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:OrdinaryShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_UnappropriatedRetainedEarningsAccumulatedDeficitMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:UnappropriatedRetainedEarningsAccumulatedDeficitMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20211231_TotalEquityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:TotalEquityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_IssuedCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20211231To20211231_PreferenceShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-12-31</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:PreferenceShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_SpecialReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SpecialReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_Others-OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Others-OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20211231_GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_ReserveOfExchangeDifferencesOnTranslationMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_PreferenceShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:PreferenceShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_ReserveOfExchangeDifferencesOnTranslationMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_Others-OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Others-OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20211231To20211231_Total3"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-12-31</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="tifrs-notes:MovementOnAllowanceForDoubtfulAccountsAbstractMemberDimensionMember">tifrs-notes:Total3</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_OrdinaryShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:OrdinaryShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20211231_Other-ShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Other-ShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20210101_GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_CapitalReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20211231_ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20211231_SecurityTokenOffer"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SecurityTokenOffer</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20210101_Others-OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Others-OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_AdvanceReceiptsForShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:AdvanceReceiptsForShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_ReserveOfExchangeDifferencesOnTranslationMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20211231_ReserveOfRemeasurementsOfDefinedBenefitPlansMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20211231_NoncontrollingInterestsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20211231To20211231_EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-12-31</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_GainsLossesOnHedgingInstrumentsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnHedgingInstrumentsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_TotalEquityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:TotalEquityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20211231"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-12-31</xbrli:instant> 
					</xbrli:period> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_IssuedCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_AdvanceReceiptsForShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:AdvanceReceiptsForShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_ReserveOfCashFlowHedgesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfCashFlowHedgesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_NoncontrollingInterestsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_PreferenceShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:PreferenceShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20211231To20211231_OrdinaryShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-12-31</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:OrdinaryShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20210101_EquityAttributableToOwnersOfParentMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_Other-ShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Other-ShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20210101_GainsLossesOnHedgingInstrumentsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnHedgingInstrumentsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20211231_SpecialReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SpecialReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_Other-ShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Other-ShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20210101_Other-ShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Other-ShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20211231To20211231_CertificateOfEntitlementToNewSharesFromConvertibleBondMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-12-31</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:CertificateOfEntitlementToNewSharesFromConvertibleBondMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20210101_UnappropriatedRetainedEarningsAccumulatedDeficitMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:UnappropriatedRetainedEarningsAccumulatedDeficitMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20211231_EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_IssuedCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_Others-OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Others-OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20211231_Other-ShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Other-ShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20211231To20211231_ReserveOfOverlayApproachMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-12-31</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfOverlayApproachMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_TotalEquityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:TotalEquityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20211231To20211231_CapitalReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-12-31</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20210101_NoncontrollingInterestsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_Total3"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="tifrs-notes:MovementOnAllowanceForDoubtfulAccountsAbstractMemberDimensionMember">tifrs-notes:Total3</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20210101_ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20211231_Others-OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Others-OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_CertificateOfEntitlementToNewSharesFromConvertibleBondMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:CertificateOfEntitlementToNewSharesFromConvertibleBondMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20210101_ReserveOfCashFlowHedgesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfCashFlowHedgesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20210101_UnappropriatedRetainedEarningsAccumulatedDeficitMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:UnappropriatedRetainedEarningsAccumulatedDeficitMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_ReserveOfOverlayApproachMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfOverlayApproachMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20211231To20211231_IssuedCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-12-31</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20211231To20211231_NoncontrollingInterestsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-12-31</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20211231To20211231_SecurityTokenOffer"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-12-31</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SecurityTokenOffer</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_CapitalReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_SecurityTokenOffer"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SecurityTokenOffer</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20210101_OrdinaryShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:OrdinaryShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20210101_SecurityTokenOffer"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SecurityTokenOffer</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20211231To20211231_RevaluationSurplusMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-12-31</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RevaluationSurplusMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20210101_CapitalReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20211231To20211231_ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-12-31</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20211231_OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_StatutoryReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:StatutoryReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_NoncontrollingInterestsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20211231_EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20211231To20211231_GainsLossesOnHedgingInstrumentsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-12-31</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnHedgingInstrumentsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20211231_ReserveOfCashFlowHedgesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfCashFlowHedgesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20210101_TotalEquityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:TotalEquityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_UnappropriatedRetainedEarningsAccumulatedDeficitMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:UnappropriatedRetainedEarningsAccumulatedDeficitMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20210101_AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_EquityAttributableToOwnersOfParentMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_ReserveOfOverlayApproachMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfOverlayApproachMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20211231_OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_ReserveOfCashFlowHedgesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfCashFlowHedgesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_SecurityTokenOffer"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SecurityTokenOffer</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20211231_OrdinaryShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:OrdinaryShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20210101_IssuedCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20211231_Total3"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="tifrs-notes:MovementOnAllowanceForDoubtfulAccountsAbstractMemberDimensionMember">tifrs-notes:Total3</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20211231_ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_CertificateOfEntitlementToNewSharesFromConvertibleBondMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:CertificateOfEntitlementToNewSharesFromConvertibleBondMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_RetainedEarningsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_TreasurySharesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_NoncontrollingInterestsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20211231_ReserveOfOverlayApproachMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfOverlayApproachMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_RetainedEarningsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20210101_OrdinaryShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:OrdinaryShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20210101_ReserveOfRemeasurementsOfDefinedBenefitPlansMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_SpecialReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SpecialReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_EquityAttributableToOwnersOfParentMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_TotalEquityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:TotalEquityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20210101_ReserveOfCashFlowHedgesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfCashFlowHedgesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20211231To20211231_TotalEquityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-12-31</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:TotalEquityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_AdvanceReceiptsForShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:AdvanceReceiptsForShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_SecurityTokenOffer"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SecurityTokenOffer</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20211231_GainsLossesOnHedgingInstrumentsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnHedgingInstrumentsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20210101_RevaluationSurplusMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RevaluationSurplusMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20211231_ReserveOfExchangeDifferencesOnTranslationMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20211231To20211231_ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-12-31</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20211231To20211231_AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-12-31</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20211231_Total3"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="tifrs-notes:MovementOnAllowanceForDoubtfulAccountsAbstractMemberDimensionMember">tifrs-notes:Total3</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20211231To20211231_ReserveOfCashFlowHedgesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-12-31</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfCashFlowHedgesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_IssuedCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20210101_EquityAttributableToOwnersOfParentMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_SecurityTokenOffer"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SecurityTokenOffer</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20211231_StockDividendToBeDistributedMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:StockDividendToBeDistributedMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_Other-ShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Other-ShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20211231_TreasurySharesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20211231_TotalEquityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:TotalEquityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20211231_ReserveOfRemeasurementsOfDefinedBenefitPlansMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20210101To20211231_CertificateOfEntitlementToNewSharesFromConvertibleBondMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2021-01-01</xbrli:startDate> 
						<xbrli:endDate>2021-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:CertificateOfEntitlementToNewSharesFromConvertibleBondMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_Other-ShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Other-ShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_StockDividendToBeDistributedMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:StockDividendToBeDistributedMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20210101_IssuedCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6499</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2021-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:unit id="TWD"> 
					<xbrli:measure>iso4217:TWD</xbrli:measure> 
				</xbrli:unit> 
				<xbrli:unit id="Shares"> 
					<xbrli:measure>xbrli:shares</xbrli:measure> 
				</xbrli:unit> 
				<xbrli:unit id="EarningsPerShare"> 
					<xbrli:divide> 
						<xbrli:unitNumerator> 
							<xbrli:measure>iso4217:TWD</xbrli:measure> 
						</xbrli:unitNumerator> 
						<xbrli:unitDenominator> 
							<xbrli:measure>xbrli:shares</xbrli:measure> 
						</xbrli:unitDenominator> 
					</xbrli:divide> 
				</xbrli:unit> 
				<xbrli:unit id="Pure"> 
					<xbrli:measure>xbrli:pure</xbrli:measure> 
				</xbrli:unit> 
			</ix:resources> 
		</ix:header> 
	</div> 
	<div class="container"> 
		<div class="header"> 
			<div> 
				<a href="javascript:showChineseReport();">中文</a>|<a href="javascript:showEnglishReport();">English</a> 
			</div> 
			<div> 
				<span class="zh">6499 益安生醫股份有限公司<br />2022年第4季合併財務報告</span> 
				<span class="en">6499 Medeon Biodesign, Inc.<br />2022Q4 Consolidated Financial Report</span> 
			</div> 
		</div> 
		<div class="nav"> 
			<div>
				<span class="zh">財務報表索引</span>
				<span class="en">Report Index</span>
			</div> 
			<ul> 
				<li>
					<a href="#BalanceSheet">
						<span class="zh">資產負債表</span>
						<span class="en">Balance Sheet</span>
					</a>
				</li>
				<li>
					<a href="#StatementOfComprehensiveIncome">
						<span class="zh">綜合損益表</span>
						<span class="en">Statement of Comprehensive Income</span>
					</a>
				</li> 
				<li>
					<a href="#StatementsOfCashFlows">
						<span class="zh">現金流量表</span>
						<span class="en">Statements of Cash Flows</span>
					</a>
				</li> 
				<li>
					<a href="#StatementsOfChangeInEquity">
						<span class="zh">權益變動表</span> 
						<span class="en">Statements of Change in Equity</span>
					</a>
				</li>
				<span class="zh">
	    			<li><a href="#ReportOfIndependentAuditors">會計師查核（核閱）報告</a></li>
	    		</span>
	    		<span class="en">
	    			<li><a href="#ReportOfIndependentAuditorsEN">Independent Auditors' (Review) Report</a></li>
	    		</span>
				<span class="zh">
	    			<li><a style="background-color:#ceceef;">財務報表附註</a></li>
	    			<li><a href="#HistoryAndOrganization">公司沿革及業務範圍</a></li>
	    			<li><a href="#DateAndProceduresOfAuthorisationForIssueOfFinancialStatements">通過財報之日期及程序</a></li>
	    			<li><a href="#ApplicationOfNewlyIssuedOrAmendedStandardsAndInterpretations">新發布及修訂準則及解釋之適用</a></li>
	    			<li><a href="#SummaryOfSignificantAccountingPolicies">重大會計政策之彙總說明</a></li>
	    			<li><a href="#SourcesOfUncertaintyFromSignificantAccountingJudgmentsAssumptionsAndEstimations">會計重大判斷、假設及估計不確性之主要來源</a></li>
	    			<li><a style="background-color:#ceceef;">其它財報附註</a></li>
	    			<li><a href="#TradeAndOtherReceivables">應收款項</a></li>
	    			<li><a href="#TransactionsBetweenRelatedParties">關係人交易</a></li>
	    			<li><a href="#LoansToOthers">資金貸與他人</a></li>
	    			<li><a href="#EndorsementGuaranteeProvidedToOthers">為他人背書保證</a></li>
	    			<li><a href="#SignificantIntercompanyTransactionsBetweenConsolidatedEntities">母子公司間業務關係及重要交易往來情形</a></li>
	    			<li><a href="#NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">被投資公司名稱、所在地區…等相關資訊</a></li>
	    			<li><a href="#InvestmentInMainlandChina">大陸地區投資</a></li>
	    			<li><a href="#NonoperatingIncomeAndExpenses">營業外收入及支出</a></li>
				</span>
			</ul> 
		</div> 
		<div class="content"> 
			<!-- 資產負債表 -->
			<div id="BalanceSheet"></div> 
			<div class="rptidx"><span class="zh">單位：新臺幣仟元</span><span class="en">Unit: NT$ thousands</span></div> 
				<table style="width:90%"> 
					<tr><th colspan="4"><span class="zh">資產負債表</span><span class="en">Balance Sheet</span></th></tr> 
					<tr> 
						<th><span class="zh">代號</span><span class="en">Code</span></th> 
						<th><span class="zh">會計項目</span><span class="en">Accounting Title</span></th> 
						<th><span class="zh">2022年12月31日</span><span class="en">2022/12/31</span></th> 
						<th><span class="zh">2021年12月31日</span><span class="en">2021/12/31</span></th> 
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">資產</span><span class="en">Assets</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　流動資產</span><span class="en">　Current assets</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1100</td> 
						<td><span class="zh">　　現金及約當現金</span><span class="en">　　Cash and cash equivalents</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CashAndCashEquivalents" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">483,898</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CashAndCashEquivalents" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">735,320</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1110</td> 
						<td><span class="zh">　　透過損益按公允價值衡量之金融資產－流動</span><span class="en">　　Current financial assets at fair value through profit or loss</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CurrentFinancialAssetsAtFairValueThroughProfitOrLoss" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">37,870</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CurrentFinancialAssetsAtFairValueThroughProfitOrLoss" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">6,479</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1136</td> 
						<td><span class="zh">　　按攤銷後成本衡量之金融資產－流動</span><span class="en">　　Current financial assets at amortised cost</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CurrentFinancialAssetsAtAmortisedCost" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,025,470</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CurrentFinancialAssetsAtAmortisedCost" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,608,100</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1170</td> 
						<td><span class="zh">　　應收帳款淨額</span><span class="en">　　Accounts receivable, net</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:AccountsReceivableNet" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">32,354</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:AccountsReceivableNet" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">10,124</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1200</td> 
						<td><span class="zh">　　其他應收款</span><span class="en">　　Other receivables</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherCurrentReceivables" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">26,653</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherCurrentReceivables" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,492</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1220</td> 
						<td><span class="zh">　　本期所得稅資產</span><span class="en">　　Current tax assets</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CurrentTaxAssets" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CurrentTaxAssets" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">629</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">130X</td> 
						<td><span class="zh">　　存貨</span><span class="en">　　Current inventories</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Inventories" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">10,059</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Inventories" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1410</td> 
						<td><span class="zh">　　預付款項</span><span class="en">　　Prepayments</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CurrentPrepayments" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">21,417</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CurrentPrepayments" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">24,684</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">11XX</td> 
						<td><span class="zh">　　流動資產合計</span><span class="en">　　Total current assets</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CurrentAssets" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,637,721</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CurrentAssets" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,389,828</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　非流動資產</span><span class="en">　Non-current assets</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1550</td> 
						<td><span class="zh">　　採用權益法之投資</span><span class="en">　　Investments accounted for using equity method</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:InvestmentAccountedForUsingEquityMethod" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,876,293</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:InvestmentAccountedForUsingEquityMethod" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,846,621</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1600</td> 
						<td><span class="zh">　　不動產、廠房及設備</span><span class="en">　　Property, plant and equipment</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">150,613</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">16,003</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1755</td> 
						<td><span class="zh">　　使用權資產</span><span class="en">　　Right-of-use assets</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:RightofuseAssets" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">189,628</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:RightofuseAssets" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">28,515</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1780</td> 
						<td><span class="zh">　　無形資產</span><span class="en">　　Intangible assets</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">180,181</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">78,939</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1900</td> 
						<td><span class="zh">　　其他非流動資產</span><span class="en">　　Other non-current assets</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherNoncurrentAssets" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">5,587</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherNoncurrentAssets" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,584</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1920</td> 
						<td><span class="zh">　　　存出保證金</span><span class="en">　　　Guarantee deposits paid</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:GuaranteeDepositsPaid" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">5,587</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:GuaranteeDepositsPaid" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,584</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">15XX</td> 
						<td><span class="zh">　　非流動資產合計</span><span class="en">　　Total non-current assets</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:NoncurrentAssets" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,402,302</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:NoncurrentAssets" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,974,662</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1XXX</td> 
						<td><span class="zh">　資產總計</span><span class="en">　Total assets</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Assets" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,040,023</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Assets" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,364,490</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">負債及權益</span><span class="en">Liabilities and equity</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　負債</span><span class="en">　Liabilities</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　　流動負債</span><span class="en">　　Current liabilities</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">2130</td> 
						<td><span class="zh">　　　合約負債－流動</span><span class="en">　　　Current contract liabilities</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CurrentContractLiabilities" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">856</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CurrentContractLiabilities" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">647</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">2170</td> 
						<td><span class="zh">　　　應付帳款</span><span class="en">　　　Accounts payable</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,939</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">45</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">2200</td> 
						<td><span class="zh">　　　其他應付款</span><span class="en">　　　Other payables</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherCurrentPayables" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">99,646</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherCurrentPayables" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">78,131</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">2230</td> 
						<td><span class="zh">　　　本期所得稅負債</span><span class="en">　　　Current tax liabilities</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CurrentTaxLiabilities" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">56,776</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CurrentTaxLiabilities" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">66,740</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">2280</td> 
						<td><span class="zh">　　　租賃負債－流動</span><span class="en">　　　Current lease liabilities</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:CurrentLeaseLiabilities" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">36,686</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:CurrentLeaseLiabilities" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">14,532</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">2300</td> 
						<td><span class="zh">　　　其他流動負債</span><span class="en">　　　Other current liabilities</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherCurrentLiabilities" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">611</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherCurrentLiabilities" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">202</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">21XX</td> 
						<td><span class="zh">　　　流動負債合計</span><span class="en">　　　Total current liabilities</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CurrentLiabilities" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">198,514</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CurrentLiabilities" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">160,297</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　　非流動負債</span><span class="en">　　Non-current liabilities</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">2570</td> 
						<td><span class="zh">　　　遞延所得稅負債</span><span class="en">　　　Deferred tax liabilities</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:DeferredTaxLiabilities" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">15,739</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:DeferredTaxLiabilities" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">2580</td> 
						<td><span class="zh">　　　租賃負債－非流動</span><span class="en">　　　Non-current lease liabilities</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:NoncurrentFinanceLeaseLiabilities" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">162,224</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:NoncurrentFinanceLeaseLiabilities" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">15,706</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">25XX</td> 
						<td><span class="zh">　　　非流動負債合計</span><span class="en">　　　Total non-current liabilities</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:NoncurrentLiabilities" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">177,963</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:NoncurrentLiabilities" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">15,706</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">2XXX</td> 
						<td><span class="zh">　　負債總計</span><span class="en">　　Total liabilities</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Liabilities" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">376,477</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Liabilities" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">176,003</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　權益</span><span class="en">　Equity</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　　歸屬於母公司業主之權益</span><span class="en">　　Equity attributable to owners of parent</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　　　股本</span><span class="en">　　　Share capital</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">3110</td> 
						<td><span class="zh">　　　　普通股股本</span><span class="en">　　　　Ordinary share</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:OrdinaryShare" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">878,401</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:OrdinaryShare" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">732,341</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">3100</td> 
						<td><span class="zh">　　　　股本合計</span><span class="en">　　　　Total Share Capital</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IssuedCapital" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">878,401</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IssuedCapital" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">732,341</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　　　資本公積</span><span class="en">　　　Capital surplus</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">3210</td> 
						<td><span class="zh">　　　　資本公積－發行溢價</span><span class="en">　　　　Capital surplus, additional paid-in capital</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:AdditionalPaidinCapital" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,331,704</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:AdditionalPaidinCapital" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,331,704</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">3220</td> 
						<td><span class="zh">　　　　資本公積－庫藏股票交易</span><span class="en">　　　　Capital surplus, treasury share transactions</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:CapitalSurplusTreasuryShareTransactions" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">5,602</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:CapitalSurplusTreasuryShareTransactions" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">5,602</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">3230</td> 
						<td><span class="zh">　　　　資本公積－實際取得或處分子公司股權價格與帳面價值差額</span><span class="en">　　　　Capital surplus, difference between consideration and carrying amount of subsidiaries acquired or disposed</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:CapitalSurplusDifferenceBetweenConsiderationAndCarryingAmountOfSubsidiariesAcquiredOrDisposed" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:CapitalSurplusDifferenceBetweenConsiderationAndCarryingAmountOfSubsidiariesAcquiredOrDisposed" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">8,548</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">3235</td> 
						<td><span class="zh">　　　　資本公積－認列對子公司所有權權益變動數</span><span class="en">　　　　Capital Surplus, changes in ownership interests in subsidiaries</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:CapitalSurplusChangesInOwnershipInterestsInSubsidiaries" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,101</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:CapitalSurplusChangesInOwnershipInterestsInSubsidiaries" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">3271</td> 
						<td><span class="zh">　　　　資本公積－員工認股權</span><span class="en">　　　　Capital surplus, employee share options</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:CapitalSurplusEmployeeShareOptions" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,406</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:CapitalSurplusEmployeeShareOptions" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,406</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">3200</td> 
						<td><span class="zh">　　　　資本公積合計</span><span class="en">　　　　Total capital surplus</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CapitalReserve" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,343,813</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CapitalReserve" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,349,260</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　　　保留盈餘</span><span class="en">　　　Retained earnings</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">3310</td> 
						<td><span class="zh">　　　　法定盈餘公積</span><span class="en">　　　　Legal reserve</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:StatutoryReserve" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">207,182</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:StatutoryReserve" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">3320</td> 
						<td><span class="zh">　　　　特別盈餘公積</span><span class="en">　　　　Special reserve</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:SpecialReserve" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">12,489</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:SpecialReserve" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">3350</td> 
						<td><span class="zh">　　　　未分配盈餘（或待彌補虧損）</span><span class="en">　　　　Unappropriated retained earnings (accumulated deficit)</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:UnappropriatedRetainedEarningsAaccumulatedDeficit" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,135,220</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:UnappropriatedRetainedEarningsAaccumulatedDeficit" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,071,824</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">3300</td> 
						<td><span class="zh">　　　　保留盈餘合計</span><span class="en">　　　　Total retained earnings</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:RetainedEarnings" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,354,891</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:RetainedEarnings" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,071,824</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　　　其他權益</span><span class="en">　　　Other equity interest</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">3410</td> 
						<td><span class="zh">　　　　國外營運機構財務報表換算之兌換差額</span><span class="en">　　　　Exchange differences on translation of foreign financial statements</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ReserveOfExchangeDifferencesOnTranslation" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">30,940</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ReserveOfExchangeDifferencesOnTranslation" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">12,489</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">3400</td> 
						<td><span class="zh">　　　　其他權益合計</span><span class="en">　　　　Total other equity interest</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherEquityInterest" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">30,940</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:OtherEquityInterest" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">12,489</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">3500</td> 
						<td><span class="zh">　　　庫藏股票</span><span class="en">　　　Treasury shares</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:TreasuryShares" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">10,603</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:TreasuryShares" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">10,603</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">31XX</td> 
						<td><span class="zh">　　　歸屬於母公司業主之權益合計</span><span class="en">　　　Total equity attributable to owners of parent</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:EquityAttributableToOwnersOfParent" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,597,442</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:EquityAttributableToOwnersOfParent" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,130,333</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">36XX</td> 
						<td><span class="zh">　　非控制權益</span><span class="en">　　Non-controlling interests</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:NoncontrollingInterests" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">66,104</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:NoncontrollingInterests" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">58,154</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">3XXX</td> 
						<td><span class="zh">　　權益總額</span><span class="en">　　Total equity</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,663,546</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,188,487</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">3X2X</td> 
						<td><span class="zh">　負債及權益總計</span><span class="en">　Total liabilities and equity</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:EquityAndLiabilities" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,040,023</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:EquityAndLiabilities" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,364,490</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">3997</td> 
						<td><span class="zh">　待註銷股本股數</span><span class="en">　Number of share capital awaiting retirement</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:NumberOfShareCapitalAwaitingRetirement" contextRef="AsOf20221231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:NumberOfShareCapitalAwaitingRetirement" contextRef="AsOf20211231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">0</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">3998</td> 
						<td><span class="zh">　預收股款（權益項下）之約當發行股數</span><span class="en">　Equivalent issue shares of advance receipts for ordinary share</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:EquivalentIssueSharesOfAdvanceReceiptsForOrdinaryShare" contextRef="AsOf20221231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:EquivalentIssueSharesOfAdvanceReceiptsForOrdinaryShare" contextRef="AsOf20211231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">0</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">3999</td> 
						<td><span class="zh">　母公司暨子公司所持有之母公司庫藏股股數（單位：股）</span><span class="en">　Number of shares in entity held by entity and by its subsidiaries</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries" contextRef="AsOf20221231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">204,000</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries" contextRef="AsOf20211231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">204,000</ix:nonFraction> </pre></td>
					</tr> 
				</table> 
				<br /> 
			<!-- 綜合損益表 -->
			<div id="StatementOfComprehensiveIncome"></div> 
			<div class="rptidx"><span class="zh">單位：新臺幣仟元　每股盈餘單位：新台幣元</span><span class="en">Unit: NT$ thousands　EPS Unit: NT$</span></div> 
				<table style="width:90%"> 
					<tr><th colspan="4"><span class="zh">綜合損益表</span><span class="en">Statement of Comprehensive Income</span></th></tr> 
					<tr> 
						<th><span class="zh">代號</span><span class="en">Code</span></th> 
						<th><span class="zh">會計項目</span><span class="en">Accounting Title</span></th> 
						<th><span class="zh">2022年1月1日至12月31日</span><span class="en">2022/1/1To12/31</span></th> 
						<th><span class="zh">2021年1月1日至12月31日</span><span class="en">2021/1/1To12/31</span></th> 
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">營業收入</span><span class="en">Operating revenue</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">4000</td> 
						<td><span class="zh">　營業收入合計</span><span class="en">　Total operating revenue</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Revenue" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">298,317</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Revenue" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">68,957</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">營業成本</span><span class="en">Operating costs</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">5000</td> 
						<td><span class="zh">　營業成本合計</span><span class="en">　Total operating costs</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:OperatingCosts" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">111,505</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:OperatingCosts" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">40,326</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">5900</td> 
						<td><span class="zh">營業毛利（毛損）</span><span class="en">Gross profit (loss) from operations</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:GrossProfitLossFromOperations" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">186,812</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:GrossProfitLossFromOperations" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">28,631</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">5950</td> 
						<td><span class="zh">營業毛利（毛損）淨額</span><span class="en">Gross profit (loss) from operations</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:GrossProfit" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">186,812</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:GrossProfit" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">28,631</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">營業費用</span><span class="en">Operating expenses</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">6100</td> 
						<td><span class="zh">　推銷費用</span><span class="en">　Selling expenses</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:SellingExpense" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">25,283</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:SellingExpense" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">42,448</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">6200</td> 
						<td><span class="zh">　管理費用</span><span class="en">　Administrative expenses</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:AdministrativeExpense" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">127,744</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:AdministrativeExpense" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">65,902</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">6300</td> 
						<td><span class="zh">　研究發展費用</span><span class="en">　Research and development expenses</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ResearchAndDevelopmentExpense" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">521,622</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ResearchAndDevelopmentExpense" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">415,870</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">6000</td> 
						<td><span class="zh">　營業費用合計</span><span class="en">　Total operating expenses</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OperatingExpense" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">674,649</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OperatingExpense" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">524,220</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">6900</td> 
						<td><span class="zh">營業利益（損失）</span><span class="en">Net operating income (loss)</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ProfitLossFromOperatingActivities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">487,837</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ProfitLossFromOperatingActivities" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">495,589</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">營業外收入及支出</span><span class="en">Non-operating income and expenses</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　利息收入</span><span class="en">　Interest income</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">7100</td> 
						<td><span class="zh">　　利息收入合計</span><span class="en">　　Total interest income</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:RevenueFromInterest" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">10,288</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:RevenueFromInterest" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">6,117</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　其他利益及損失</span><span class="en">　Other gains and losses</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">7020</td> 
						<td><span class="zh">　　其他利益及損失淨額</span><span class="en">　　Other gains and losses, net</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:OtherGainsLosses" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">4,044</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:OtherGainsLosses" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">43,072</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　財務成本</span><span class="en">　Finance costs</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">7050</td> 
						<td><span class="zh">　　財務成本淨額</span><span class="en">　　Finance costs, net</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:FinanceCosts" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">5,211</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:FinanceCosts" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,027</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　採用權益法認列之關聯企業及合資損益之份額</span><span class="en">　Share of profit (loss) of associates and joint ventures accounted for using equity method</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">7060</td> 
						<td><span class="zh">　　採用權益法認列之關聯企業及合資損益之份額淨額</span><span class="en">　　Share of profit (loss) of associates and joint ventures accounted for using equity method, net</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">47,689</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">19,664</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">7000</td> 
						<td><span class="zh">　營業外收入及支出合計</span><span class="en">　Total non-operating income and expenses</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:NonoperatingIncomeAndExpenses" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">48,722</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-bsci-ci:NonoperatingIncomeAndExpenses" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">18,318</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">7900</td> 
						<td><span class="zh">繼續營業單位稅前淨利（淨損）</span><span class="en">Profit (loss) from continuing operations before tax</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">439,115</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">513,907</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">所得稅費用（利益）</span><span class="en">Tax expense (income)</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">7950</td> 
						<td><span class="zh">　所得稅費用（利益）合計</span><span class="en">　Total tax expense (income)</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IncomeTaxExpenseContinuingOperations" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">57,785</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IncomeTaxExpenseContinuingOperations" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">72,457</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">8000</td> 
						<td><span class="zh">繼續營業單位本期淨利（淨損）</span><span class="en">Profit (loss) from continuing operations</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ProfitLossFromContinuingOperations" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">496,900</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ProfitLossFromContinuingOperations" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">586,364</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">停業單位損益</span><span class="en">Profit (loss) from discontinued operations</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">8100</td> 
						<td><span class="zh">　停業單位損益合計</span><span class="en">　Total profit (loss) from discontinued operations</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLossFromDiscontinuedOperations" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLossFromDiscontinuedOperations" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,617,810</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">8200</td> 
						<td><span class="zh">本期淨利（淨損）</span><span class="en">Profit (loss)</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">496,900</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,031,446</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">其他綜合損益(淨額)</span><span class="en">Other comprehensive income</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　後續可能重分類至損益之項目</span><span class="en">　Components of other comprehensive income that will be reclassified to profit or loss</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">8361</td> 
						<td><span class="zh">　　國外營運機構財務報表換算之兌換差額</span><span class="en">　　Exchange differences on translation</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">36,909</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">1,418</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">8360</td> 
						<td><span class="zh">　　後續可能重分類至損益之項目總額</span><span class="en">　　Components of other comprehensive income that will be reclassified to profit or loss</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">36,909</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">1,418</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">8300</td> 
						<td><span class="zh">　其他綜合損益（淨額）</span><span class="en">　Total other comprehensive income</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">36,909</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">1,418</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">8500</td> 
						<td><span class="zh">本期綜合損益總額</span><span class="en">Total comprehensive income</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">459,991</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,030,028</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">淨利（損）歸屬於：</span><span class="en">Profit (loss), attributable to:</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">8610</td> 
						<td><span class="zh">　母公司業主（淨利／損）</span><span class="en">　Profit (loss), attributable to owners of parent</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ProfitLossAttributableToOwnersOfParent" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">433,758</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLossAttributableToOwnersOfParent" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,078,192</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">8620</td> 
						<td><span class="zh">　非控制權益（淨利／損）</span><span class="en">　Profit (loss), attributable to non-controlling interests</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">63,142</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">46,746</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">綜合損益總額歸屬於：</span><span class="en">Comprehensive income attributable to:</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">8710</td> 
						<td><span class="zh">　母公司業主（綜合損益）</span><span class="en">　Comprehensive income, attributable to owners of parent</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">390,329</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,072,384</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">8720</td> 
						<td><span class="zh">　非控制權益（綜合損益）</span><span class="en">　Comprehensive income, attributable to non-controlling interests</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">69,662</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">42,356</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">基本每股盈餘</span><span class="en">Basic earnings per share</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">9710</td> 
						<td><span class="zh">　繼續營業單位淨利（淨損）</span><span class="en">　Basic earnings (loss) per share from continuing operations</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:BasicEarningsLossPerShareFromContinuingOperations" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="0" sign="-" decimals="2" unitRef="EarningsPerShare">4.95</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:BasicEarningsLossPerShareFromContinuingOperations" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="0" sign="-" decimals="2" unitRef="EarningsPerShare">5.84</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">9720</td> 
						<td><span class="zh">　停業單位淨利（淨損）</span><span class="en">　Basic earnings (loss) per share from discontinued operations</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:BasicEarningsLossPerShareFromDiscontinuedOperations" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="0" decimals="2" unitRef="EarningsPerShare">0.00</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:BasicEarningsLossPerShareFromDiscontinuedOperations" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="0" decimals="2" unitRef="EarningsPerShare">29.62</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">9750</td> 
						<td><span class="zh">　基本每股盈餘合計</span><span class="en">　Total basic earnings per share</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:BasicEarningsLossPerShare" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="0" sign="-" decimals="2" unitRef="EarningsPerShare">4.95</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:BasicEarningsLossPerShare" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="0" decimals="2" unitRef="EarningsPerShare">23.78</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">稀釋每股盈餘</span><span class="en">Diluted earnings per share</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">9810</td> 
						<td><span class="zh">　繼續營業單位淨利（淨損）</span><span class="en">　Diluted earnings (loss) per share from continuing operations</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:DilutedEarningsLossPerShareFromContinuingOperations" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="0" sign="-" decimals="2" unitRef="EarningsPerShare">4.95</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:DilutedEarningsLossPerShareFromContinuingOperations" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="0" sign="-" decimals="2" unitRef="EarningsPerShare">5.81</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">9820</td> 
						<td><span class="zh">　停業單位淨利（淨損）</span><span class="en">　Diluted earnings (loss) per share from discontinued operations</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:DilutedEarningsLossPerShareFromDiscontinuedOperations" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="0" decimals="2" unitRef="EarningsPerShare">0.00</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:DilutedEarningsLossPerShareFromDiscontinuedOperations" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="0" decimals="2" unitRef="EarningsPerShare">29.51</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">9850</td> 
						<td><span class="zh">　稀釋每股盈餘合計</span><span class="en">　Total diluted earnings per share</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:DilutedEarningsLossPerShare" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="0" sign="-" decimals="2" unitRef="EarningsPerShare">4.95</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:DilutedEarningsLossPerShare" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="0" decimals="2" unitRef="EarningsPerShare">23.70</ix:nonFraction> </pre></td>
					</tr> 
				</table> 
				<br /> 
			<!-- 現金流量表 -->
			<div id="StatementsOfCashFlows"></div> 
			<div class="rptidx"><span class="zh">單位：新臺幣仟元</span><span class="en">Unit: NT$ thousands</span></div> 
				<table style="width:90%"> 
					<tr><th colspan="4"><span class="zh">現金流量表</span><span class="en">Statements of Cash Flows</span></th></tr> 
					<tr> 
						<th><span class="zh">代號</span><span class="en">Code</span></th> 
						<th><span class="zh">會計項目</span><span class="en">Accounting Title</span></th> 
						<th><span class="zh">2022年1月1日至12月31日</span><span class="en">2022/1/1To12/31</span></th> 
						<th><span class="zh">2021年1月1日至12月31日</span><span class="en">2021/1/1To12/31</span></th> 
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">營業活動之現金流量－間接法</span><span class="en">Cash flows from (used in) operating activities, indirect method</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A00010</td> 
						<td><span class="zh">　繼續營業單位稅前淨利（淨損）</span><span class="en">　Profit (loss) from continuing operations before tax</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">439,115</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">513,907</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A00020</td> 
						<td><span class="zh">　停業單位稅前淨利（淨損）</span><span class="en">　Profit (loss) from discontinued operations before tax</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:ProfitLossFromDiscontinuedOperationsBeforeTax" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:ProfitLossFromDiscontinuedOperationsBeforeTax" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,634,218</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A10000</td> 
						<td><span class="zh">　本期稅前淨利（淨損）</span><span class="en">　Profit (loss) before tax</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:ProfitLossBeforeTax" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">439,115</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:ProfitLossBeforeTax" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,120,311</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　調整項目</span><span class="en">　Adjustments</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　　收益費損項目</span><span class="en">　　Adjustments to reconcile profit (loss)</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A20100</td> 
						<td><span class="zh">　　　折舊費用</span><span class="en">　　　Depreciation expense</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:AdjustmentsForDepreciationExpense" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">47,218</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:AdjustmentsForDepreciationExpense" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">42,882</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A20200</td> 
						<td><span class="zh">　　　攤銷費用</span><span class="en">　　　Amortization expense</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:AdjustmentsForAmortisationExpense" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">16,582</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:AdjustmentsForAmortisationExpense" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">16,133</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A20300</td> 
						<td><span class="zh">　　　預期信用減損損失（利益）數／呆帳費用提列（轉列收入）數</span><span class="en">　　　Expected credit loss (gain) / Provision (reversal of provision) for bad debt expense</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:ProvisionReversalOfProvisionForBadDebtExpense" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:ProvisionReversalOfProvisionForBadDebtExpense" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">359</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A20400</td> 
						<td><span class="zh">　　　透過損益按公允價值衡量金融資產及負債之淨損失（利益）</span><span class="en">　　　Net loss (gain) on financial assets or liabilities at fair value through profit or loss</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:NetLossGainOnFinancialAssetsOrLiabilitiesAtFairValueThroughProfitOrLoss" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">681</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:NetLossGainOnFinancialAssetsOrLiabilitiesAtFairValueThroughProfitOrLoss" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">2,479</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A20900</td> 
						<td><span class="zh">　　　利息費用</span><span class="en">　　　Interest expense</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:AdjustmentsForInterestExpense" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,596</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:AdjustmentsForInterestExpense" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,430</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A21200</td> 
						<td><span class="zh">　　　利息收入</span><span class="en">　　　Interest income</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:AdjustmentsForInterestIncome" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">10,288</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:AdjustmentsForInterestIncome" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">6,864</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A21300</td> 
						<td><span class="zh">　　　股利收入</span><span class="en">　　　Dividend income</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:AdjustmentsForDividendIncome" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">160</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:AdjustmentsForDividendIncome" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A21900</td> 
						<td><span class="zh">　　　股份基礎給付酬勞成本</span><span class="en">　　　Share-based payments</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:AdjustmentsForSharebasedPayments" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,106</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:AdjustmentsForSharebasedPayments" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">5,952</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A22300</td> 
						<td><span class="zh">　　　採用權益法認列之關聯企業及合資損失（利益）之份額</span><span class="en">　　　Share of loss (profit) of associates and joint ventures accounted for using equity method</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:ShareOfLossProfitOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">47,689</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:ShareOfLossProfitOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">19,664</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A23100</td> 
						<td><span class="zh">　　　處分投資損失（利益）</span><span class="en">　　　Loss (gain) on disposal of investments</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:LossGainOnDisposalOfInvestments" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:LossGainOnDisposalOfInvestments" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">2,504,096</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A29900</td> 
						<td><span class="zh">　　　其他項目</span><span class="en">　　　Other adjustments to reconcile profit (loss)</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherAdjustmentsToReconcileProfitLoss" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:OtherAdjustmentsToReconcileProfitLoss" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">12,755</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A20010</td> 
						<td><span class="zh">　　　收益費損項目合計</span><span class="en">　　　Total adjustments to reconcile profit (loss)</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:AdjustmentsToReconcileProfitLoss" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">12,684</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:AdjustmentsToReconcileProfitLoss" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">2,476,820</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　　與營業活動相關之資產／負債變動數</span><span class="en">　　Changes in operating assets and liabilities</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　　　與營業活動相關之資產之淨變動</span><span class="en">　　　Changes in operating assets</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A31150</td> 
						<td><span class="zh">　　　　應收帳款（增加）減少</span><span class="en">　　　　Decrease (increase) in accounts receivable</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:DecreaseIncreaseInAccountsReceivable" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">5,302</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:DecreaseIncreaseInAccountsReceivable" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">39,646</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A31180</td> 
						<td><span class="zh">　　　　其他應收款（增加）減少</span><span class="en">　　　　Decrease (increase) in other receivable</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:DecreaseIncreaseInOtherReceivables" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">11,388</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:DecreaseIncreaseInOtherReceivables" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">1,747</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A31200</td> 
						<td><span class="zh">　　　　存貨（增加）減少</span><span class="en">　　　　Adjustments for decrease (increase) in inventories</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:AdjustmentsForDecreaseIncreaseInInventories" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">4,397</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:AdjustmentsForDecreaseIncreaseInInventories" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">10,042</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A31230</td> 
						<td><span class="zh">　　　　預付款項（增加）減少</span><span class="en">　　　　Decrease (increase) in prepayments</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:DecreaseIncreaseInPrepayments" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">8,887</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:DecreaseIncreaseInPrepayments" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">6,235</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A31000</td> 
						<td><span class="zh">　　　　與營業活動相關之資產之淨變動合計</span><span class="en">　　　　Total changes in operating assets</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:ChangesInOperatingAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">21,180</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:ChangesInOperatingAssets" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">21,622</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　　　與營業活動相關之負債之淨變動</span><span class="en">　　　Changes in operating liabilities</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A32125</td> 
						<td><span class="zh">　　　　合約負債增加（減少）</span><span class="en">　　　　Increase (decrease) in contract liabilities</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:IncreaseDecreaseInContractLiabilities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">209</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:IncreaseDecreaseInContractLiabilities" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">8,179</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A32150</td> 
						<td><span class="zh">　　　　應付帳款增加（減少）</span><span class="en">　　　　Increase (decrease) in accounts payable</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:IncreaseDecreaseInAccountsPayable" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,870</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:IncreaseDecreaseInAccountsPayable" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,420</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A32180</td> 
						<td><span class="zh">　　　　其他應付款增加（減少）</span><span class="en">　　　　Increase (decrease) in other payable</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:IncreaseDecreaseInOtherPayables" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">6,171</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:IncreaseDecreaseInOtherPayables" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">44,415</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A32230</td> 
						<td><span class="zh">　　　　其他流動負債增加（減少）</span><span class="en">　　　　Adjustments for increase (decrease) in other current liabilities</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">409</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">125</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A32000</td> 
						<td><span class="zh">　　　　與營業活動相關之負債之淨變動合計</span><span class="en">　　　　Total changes in operating liabilities</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:ChangesInOperatingLiabilities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">9,659</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:ChangesInOperatingLiabilities" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">40,781</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A30000</td> 
						<td><span class="zh">　　　與營業活動相關之資產及負債之淨變動合計</span><span class="en">　　　Total changes in operating assets and liabilities</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:ChangesInOperatingAssetsAndLiabilities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">30,839</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:ChangesInOperatingAssetsAndLiabilities" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">62,403</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A20000</td> 
						<td><span class="zh">　　調整項目合計</span><span class="en">　　Total adjustments</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:Adjustments" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">43,523</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:Adjustments" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">2,414,417</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A33000</td> 
						<td><span class="zh">　營運產生之現金流入（流出）</span><span class="en">　Cash inflow (outflow) generated from operations</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:CashFlowsFromUsedInOperations" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">395,592</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:CashFlowsFromUsedInOperations" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">294,106</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A33100</td> 
						<td><span class="zh">　收取之利息</span><span class="en">　Interest received</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:InterestReceivedClassifiedAsOperatingActivities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">8,057</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:InterestReceivedClassifiedAsOperatingActivities" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">6,635</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A33300</td> 
						<td><span class="zh">　支付之利息</span><span class="en">　Interest paid</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:InterestPaidClassifiedAsOperatingActivities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">4,596</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:InterestPaidClassifiedAsOperatingActivities" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">1,553</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A33500</td> 
						<td><span class="zh">　退還（支付）之所得稅</span><span class="en">　Income taxes refund (paid)</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">69,209</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">4,353</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">AAAA</td> 
						<td><span class="zh">營業活動之淨現金流入（流出）</span><span class="en">Net cash flows from (used in) operating activities</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:CashFlowsFromUsedInOperatingActivities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">461,340</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:CashFlowsFromUsedInOperatingActivities" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">293,377</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">投資活動之現金流量</span><span class="en">Cash flows from (used in) investing activities</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">B00040</td> 
						<td><span class="zh">　取得按攤銷後成本衡量之金融資產</span><span class="en">　Acquisition of financial assets at amortised cost</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:AcquisitionOfFinancialAssetsAtAmortisedCost" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:AcquisitionOfFinancialAssetsAtAmortisedCost" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">842,762</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">B00050</td> 
						<td><span class="zh">　處分按攤銷後成本衡量之金融資產</span><span class="en">　Proceeds from disposal of financial assets at amortised cost</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:ProceedsFromDisposalOfFinancialAssetsAtAmortisedCost" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">582,630</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:ProceedsFromDisposalOfFinancialAssetsAtAmortisedCost" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">B00100</td> 
						<td><span class="zh">　取得透過損益按公允價值衡量之金融資產</span><span class="en">　Acquisition of financial assets at fair value through profit or loss</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:AcquisitionOfFinancialAssetsAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognition" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">29,720</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:AcquisitionOfFinancialAssetsAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognition" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">4,000</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">B01900</td> 
						<td><span class="zh">　處分採用權益法之投資</span><span class="en">　Proceeds from disposal of investments accounted for using equity method</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">310,839</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">B02200</td> 
						<td><span class="zh">　對子公司之收購（扣除所取得之現金）</span><span class="en">　Net cash flow from acquisition of subsidiaries</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">165,888</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,210</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">B02300</td> 
						<td><span class="zh">　處分子公司</span><span class="en">　Proceeds from disposal of subsidiaries</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">450,922</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">B02700</td> 
						<td><span class="zh">　取得不動產、廠房及設備</span><span class="en">　Acquisition of property, plant and equipment</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">140,572</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">8,317</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">B03700</td> 
						<td><span class="zh">　存出保證金增加</span><span class="en">　Increase in refundable deposits</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:IncreaseInRefundableDeposits" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">1,046</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:IncreaseInRefundableDeposits" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">832</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">B04500</td> 
						<td><span class="zh">　取得無形資產</span><span class="en">　Acquisition of intangible assets</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">145</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">695</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">B07600</td> 
						<td><span class="zh">　收取之股利</span><span class="en">　Dividends received</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:DividendsReceivedClassifiedAsInvestingActivities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">18,177</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:DividendsReceivedClassifiedAsInvestingActivities" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">BBBB</td> 
						<td><span class="zh">　投資活動之淨現金流入（流出）</span><span class="en">　Net cash flows from (used in) investing activities</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:NetCashFlowsFromUsedInInvestingActivities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">263,436</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:NetCashFlowsFromUsedInInvestingActivities" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">90,635</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">籌資活動之現金流量</span><span class="en">Cash flows from (used in) financing activities</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">C04020</td> 
						<td><span class="zh">　租賃本金償還</span><span class="en">　Payments of lease liabilities</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">29,172</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">17,395</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">C04500</td> 
						<td><span class="zh">　發放現金股利</span><span class="en">　Cash dividends paid</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:DividendsPaidClassifiedAsFinancingActivities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">73,030</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:DividendsPaidClassifiedAsFinancingActivities" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">C04800</td> 
						<td><span class="zh">　員工執行認股權</span><span class="en">　Exercise of employee share options</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:ExerciseOfEmployeeShareOptions" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:ExerciseOfEmployeeShareOptions" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,150</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">C05100</td> 
						<td><span class="zh">　員工購買庫藏股</span><span class="en">　Treasury shares sold to employees</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:TreasurySharesSoldToEmployees" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:TreasurySharesSoldToEmployees" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">8,945</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">C05800</td> 
						<td><span class="zh">　非控制權益變動</span><span class="en">　Change in non-controlling interests</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:ChangeInNoncontrollingInterests" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,045</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:ChangeInNoncontrollingInterests" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">C09900</td> 
						<td><span class="zh">　其他籌資活動</span><span class="en">　Other financing activities</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,398</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">CCCC</td> 
						<td><span class="zh">　籌資活動之淨現金流入（流出）</span><span class="en">　Net cash flows from (used in) financing activities</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:CashFlowsFromUsedInFinancingActivities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">101,157</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:CashFlowsFromUsedInFinancingActivities" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">3,902</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">DDDD</td> 
						<td><span class="zh">匯率變動對現金及約當現金之影響</span><span class="en">Effect of exchange rate changes on cash and cash equivalents</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">47,639</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">4,891</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">EEEE</td> 
						<td><span class="zh">本期現金及約當現金增加（減少）數</span><span class="en">Net increase (decrease) in cash and cash equivalents</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalents" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">251,422</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalents" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">392,805</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">E00100</td> 
						<td><span class="zh">期初現金及約當現金餘額</span><span class="en">Cash and cash equivalents at beginning of period</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:CashAndCashEquivalentsAtBeginningOfPeriod" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">735,320</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:CashAndCashEquivalentsAtBeginningOfPeriod" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,128,125</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">E00200</td> 
						<td><span class="zh">期末現金及約當現金餘額</span><span class="en">Cash and cash equivalents at end of period</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:CashAndCashEquivalentsAtEndOfPeriod" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">483,898</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:CashAndCashEquivalentsAtEndOfPeriod" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">735,320</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">E00210</td> 
						<td><span class="zh">　資產負債表帳列之現金及約當現金</span><span class="en">　Cash and cash equivalents reported in the statement of financial position</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CashAndCashEquivalents" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">483,898</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CashAndCashEquivalents" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">735,320</ix:nonFraction> </pre></td>
					</tr> 

				</table> 
				<br /> 
			<!-- 當期權益變動表 -->
			<div id="StatementsOfChangeInEquity"></div> 
			<div class="rptidx"><span class="zh">單位：新臺幣仟元</span><span class="en">Unit: NT$ thousands</span></div> 
				<table style="width:150%"> 
					<tr> 
						<th colspan="32"> 
							<span class="zh">當期權益變動表</span><span class="en">Statements of Change in Equity</span> 
						</th> 
					</tr> 
					<tr> 
						<th colspan='2' rowspan='2'></th> 
						<th>3110</th>
						<th>3100</th>
						<th>3200</th>
						<th>3310</th>
						<th>3320</th>
						<th>3350</th>
						<th>3300</th>
						<th>3410</th>
						<th>3400</th>
						<th>3500</th>
						<th>31XX</th>
						<th>36XX</th>
						<th>3XXX</th>
					</tr> 
					<tr> 
						<th> 
							<span class="zh">普通股股本</span> 
							<span class="en">　　　　　Ordinary share</span> 
						</th>
						<th> 
							<span class="zh">股本合計</span> 
							<span class="en">　　　　Total share capital</span> 
						</th>
						<th> 
							<span class="zh">資本公積</span> 
							<span class="en">　　　　Capital surplus</span> 
						</th>
						<th> 
							<span class="zh">法定盈餘公積</span> 
							<span class="en">　　　　　Legal reserve</span> 
						</th>
						<th> 
							<span class="zh">特別盈餘公積</span> 
							<span class="en">　　　　　Special reserve</span> 
						</th>
						<th> 
							<span class="zh">未分配盈餘（或待彌補虧損）</span> 
							<span class="en">　　　　　Unappropriated retained earnings (accumulated deficit)</span> 
						</th>
						<th> 
							<span class="zh">保留盈餘合計</span> 
							<span class="en">　　　　Total retained earnings</span> 
						</th>
						<th> 
							<span class="zh">國外營運機構財務報表換算之兌換差額</span> 
							<span class="en">　　　　　Exchange differences on translation of foreign financial statements</span> 
						</th>
						<th> 
							<span class="zh">其他權益項目合計</span> 
							<span class="en">　　　　Total other equity interest</span> 
						</th>
						<th> 
							<span class="zh">庫藏股票</span> 
							<span class="en">　　　　Treasury shares</span> 
						</th>
						<th> 
							<span class="zh">歸屬於母公司業主之權益總計</span> 
							<span class="en">　　　Total equity attributable to owners of parent</span> 
						</th>
						<th> 
							<span class="zh">非控制權益</span> 
							<span class="en">　　　Non-controlling interests</span> 
						</th>
						<th> 
							<span class="zh">權益總額</span> 
							<span class="en">　　Total equity</span> 
						</th>
					</tr> 
					<tr> 
						<td>A1</td> 
						<td> 
							<span class="zh">期初餘額</span> 
							<span class="en">　Equity at beginning of period</span> 
						</td> 
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20220101_OrdinaryShareMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">732,341</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20220101_IssuedCapitalMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">732,341</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20220101_CapitalReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,349,260</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20220101_StatutoryReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20220101_SpecialReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20220101_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,071,824</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20220101_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,071,824</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20220101_ReserveOfExchangeDifferencesOnTranslationMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">12,489</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20220101_OtherEquityInterestMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">12,489</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20220101_TreasurySharesMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">10,603</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20220101_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,130,333</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20220101_NoncontrollingInterestsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">58,154</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20220101_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,188,487</ix:nonFraction> </pre></td>
					</tr>
					<tr> 
						<td>B1</td> 
						<td> 
							<span class="zh">提列法定盈餘公積</span> 
							<span class="en">　　Legal reserve appropriated</span> 
						</td> 
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:LegalReserveAppropriated" contextRef="From20220101To20221231_OrdinaryShareMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:LegalReserveAppropriated" contextRef="From20220101To20221231_IssuedCapitalMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:LegalReserveAppropriated" contextRef="From20220101To20221231_CapitalReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:LegalReserveAppropriated" contextRef="From20220101To20221231_StatutoryReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">207,182</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:LegalReserveAppropriated" contextRef="From20220101To20221231_SpecialReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-es:LegalReserveAppropriated" contextRef="From20220101To20221231_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">207,182</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:LegalReserveAppropriated" contextRef="From20220101To20221231_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:LegalReserveAppropriated" contextRef="From20220101To20221231_ReserveOfExchangeDifferencesOnTranslationMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:LegalReserveAppropriated" contextRef="From20220101To20221231_OtherEquityInterestMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:LegalReserveAppropriated" contextRef="From20220101To20221231_TreasurySharesMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:LegalReserveAppropriated" contextRef="From20220101To20221231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:LegalReserveAppropriated" contextRef="From20220101To20221231_NoncontrollingInterestsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:LegalReserveAppropriated" contextRef="From20220101To20221231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr>
					<tr> 
						<td>B3</td> 
						<td> 
							<span class="zh">提列特別盈餘公積</span> 
							<span class="en">　　Special reserve appropriated</span> 
						</td> 
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:SpecialReserveAppropriated" contextRef="From20220101To20221231_OrdinaryShareMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:SpecialReserveAppropriated" contextRef="From20220101To20221231_IssuedCapitalMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:SpecialReserveAppropriated" contextRef="From20220101To20221231_CapitalReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:SpecialReserveAppropriated" contextRef="From20220101To20221231_StatutoryReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:SpecialReserveAppropriated" contextRef="From20220101To20221231_SpecialReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">12,489</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-es:SpecialReserveAppropriated" contextRef="From20220101To20221231_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">12,489</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:SpecialReserveAppropriated" contextRef="From20220101To20221231_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:SpecialReserveAppropriated" contextRef="From20220101To20221231_ReserveOfExchangeDifferencesOnTranslationMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:SpecialReserveAppropriated" contextRef="From20220101To20221231_OtherEquityInterestMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:SpecialReserveAppropriated" contextRef="From20220101To20221231_TreasurySharesMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:SpecialReserveAppropriated" contextRef="From20220101To20221231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:SpecialReserveAppropriated" contextRef="From20220101To20221231_NoncontrollingInterestsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:SpecialReserveAppropriated" contextRef="From20220101To20221231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr>
					<tr> 
						<td>B5</td> 
						<td> 
							<span class="zh">普通股現金股利</span> 
							<span class="en">　　Cash dividends of ordinary share</span> 
						</td> 
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:CashDividendsOfOrdinaryShare" contextRef="From20220101To20221231_OrdinaryShareMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:CashDividendsOfOrdinaryShare" contextRef="From20220101To20221231_IssuedCapitalMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:CashDividendsOfOrdinaryShare" contextRef="From20220101To20221231_CapitalReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:CashDividendsOfOrdinaryShare" contextRef="From20220101To20221231_StatutoryReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:CashDividendsOfOrdinaryShare" contextRef="From20220101To20221231_SpecialReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-es:CashDividendsOfOrdinaryShare" contextRef="From20220101To20221231_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">73,030</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-es:CashDividendsOfOrdinaryShare" contextRef="From20220101To20221231_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">73,030</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:CashDividendsOfOrdinaryShare" contextRef="From20220101To20221231_ReserveOfExchangeDifferencesOnTranslationMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:CashDividendsOfOrdinaryShare" contextRef="From20220101To20221231_OtherEquityInterestMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:CashDividendsOfOrdinaryShare" contextRef="From20220101To20221231_TreasurySharesMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-es:CashDividendsOfOrdinaryShare" contextRef="From20220101To20221231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">73,030</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:CashDividendsOfOrdinaryShare" contextRef="From20220101To20221231_NoncontrollingInterestsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-es:CashDividendsOfOrdinaryShare" contextRef="From20220101To20221231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">73,030</ix:nonFraction>)</pre></td>
					</tr>
					<tr> 
						<td>B9</td> 
						<td> 
							<span class="zh">普通股股票股利</span> 
							<span class="en">　　Stock dividends of ordinary share</span> 
						</td> 
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:StockDividendsOfOrdinaryShare" contextRef="From20220101To20221231_OrdinaryShareMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">146,060</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:StockDividendsOfOrdinaryShare" contextRef="From20220101To20221231_IssuedCapitalMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">146,060</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:StockDividendsOfOrdinaryShare" contextRef="From20220101To20221231_CapitalReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:StockDividendsOfOrdinaryShare" contextRef="From20220101To20221231_StatutoryReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:StockDividendsOfOrdinaryShare" contextRef="From20220101To20221231_SpecialReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-es:StockDividendsOfOrdinaryShare" contextRef="From20220101To20221231_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">146,060</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-es:StockDividendsOfOrdinaryShare" contextRef="From20220101To20221231_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">146,060</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:StockDividendsOfOrdinaryShare" contextRef="From20220101To20221231_ReserveOfExchangeDifferencesOnTranslationMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:StockDividendsOfOrdinaryShare" contextRef="From20220101To20221231_OtherEquityInterestMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:StockDividendsOfOrdinaryShare" contextRef="From20220101To20221231_TreasurySharesMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:StockDividendsOfOrdinaryShare" contextRef="From20220101To20221231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:StockDividendsOfOrdinaryShare" contextRef="From20220101To20221231_NoncontrollingInterestsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:StockDividendsOfOrdinaryShare" contextRef="From20220101To20221231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr>
					<tr> 
						<td>D1</td> 
						<td> 
							<span class="zh">本期淨利（淨損）</span> 
							<span class="en">　Profit (loss)</span> 
						</td> 
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From20220101To20221231_OrdinaryShareMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From20220101To20221231_IssuedCapitalMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From20220101To20221231_CapitalReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From20220101To20221231_StatutoryReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From20220101To20221231_SpecialReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From20220101To20221231_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">433,758</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From20220101To20221231_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">433,758</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From20220101To20221231_ReserveOfExchangeDifferencesOnTranslationMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From20220101To20221231_OtherEquityInterestMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From20220101To20221231_TreasurySharesMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From20220101To20221231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">433,758</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From20220101To20221231_NoncontrollingInterestsMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">63,142</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From20220101To20221231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">496,900</ix:nonFraction>)</pre></td>
					</tr>
					<tr> 
						<td>D3</td> 
						<td> 
							<span class="zh">本期其他綜合損益</span> 
							<span class="en">　Other comprehensive income</span> 
						</td> 
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20220101To20221231_OrdinaryShareMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20220101To20221231_IssuedCapitalMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20220101To20221231_CapitalReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20220101To20221231_StatutoryReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20220101To20221231_SpecialReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20220101To20221231_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20220101To20221231_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20220101To20221231_ReserveOfExchangeDifferencesOnTranslationMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">43,429</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20220101To20221231_OtherEquityInterestMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">43,429</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20220101To20221231_TreasurySharesMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20220101To20221231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">43,429</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20220101To20221231_NoncontrollingInterestsMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">6,520</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20220101To20221231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">36,909</ix:nonFraction> </pre></td>
					</tr>
					<tr> 
						<td>D5</td> 
						<td> 
							<span class="zh">本期綜合損益總額</span> 
							<span class="en">　Total comprehensive income</span> 
						</td> 
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20220101To20221231_OrdinaryShareMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20220101To20221231_IssuedCapitalMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20220101To20221231_CapitalReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20220101To20221231_StatutoryReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20220101To20221231_SpecialReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20220101To20221231_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">433,758</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20220101To20221231_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">433,758</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20220101To20221231_ReserveOfExchangeDifferencesOnTranslationMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">43,429</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20220101To20221231_OtherEquityInterestMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">43,429</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20220101To20221231_TreasurySharesMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20220101To20221231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">390,329</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20220101To20221231_NoncontrollingInterestsMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">69,662</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20220101To20221231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">459,991</ix:nonFraction>)</pre></td>
					</tr>
					<tr> 
						<td>M5</td> 
						<td> 
							<span class="zh">實際取得或處分子公司股權價格與帳面價值差額</span> 
							<span class="en">　Difference between consideration and carrying amount of subsidiaries acquired or disposed</span> 
						</td> 
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:DifferenceBetweenConsiderationAndCarryingAmountOfSubsidiariesAcquiredOrDisposed" contextRef="From20220101To20221231_OrdinaryShareMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:DifferenceBetweenConsiderationAndCarryingAmountOfSubsidiariesAcquiredOrDisposed" contextRef="From20220101To20221231_IssuedCapitalMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:DifferenceBetweenConsiderationAndCarryingAmountOfSubsidiariesAcquiredOrDisposed" contextRef="From20220101To20221231_CapitalReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:DifferenceBetweenConsiderationAndCarryingAmountOfSubsidiariesAcquiredOrDisposed" contextRef="From20220101To20221231_StatutoryReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:DifferenceBetweenConsiderationAndCarryingAmountOfSubsidiariesAcquiredOrDisposed" contextRef="From20220101To20221231_SpecialReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:DifferenceBetweenConsiderationAndCarryingAmountOfSubsidiariesAcquiredOrDisposed" contextRef="From20220101To20221231_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:DifferenceBetweenConsiderationAndCarryingAmountOfSubsidiariesAcquiredOrDisposed" contextRef="From20220101To20221231_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:DifferenceBetweenConsiderationAndCarryingAmountOfSubsidiariesAcquiredOrDisposed" contextRef="From20220101To20221231_ReserveOfExchangeDifferencesOnTranslationMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:DifferenceBetweenConsiderationAndCarryingAmountOfSubsidiariesAcquiredOrDisposed" contextRef="From20220101To20221231_OtherEquityInterestMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:DifferenceBetweenConsiderationAndCarryingAmountOfSubsidiariesAcquiredOrDisposed" contextRef="From20220101To20221231_TreasurySharesMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:DifferenceBetweenConsiderationAndCarryingAmountOfSubsidiariesAcquiredOrDisposed" contextRef="From20220101To20221231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:DifferenceBetweenConsiderationAndCarryingAmountOfSubsidiariesAcquiredOrDisposed" contextRef="From20220101To20221231_NoncontrollingInterestsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,929</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:DifferenceBetweenConsiderationAndCarryingAmountOfSubsidiariesAcquiredOrDisposed" contextRef="From20220101To20221231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,929</ix:nonFraction> </pre></td>
					</tr>
					<tr> 
						<td>M7</td> 
						<td> 
							<span class="zh">對子公司所有權權益變動</span> 
							<span class="en">　Changes in ownership interests in subsidiaries</span> 
						</td> 
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:ChangesInOwnershipInterestsInSubsidiaries" contextRef="From20220101To20221231_OrdinaryShareMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:ChangesInOwnershipInterestsInSubsidiaries" contextRef="From20220101To20221231_IssuedCapitalMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-es:ChangesInOwnershipInterestsInSubsidiaries" contextRef="From20220101To20221231_CapitalReserveMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">8,548</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:ChangesInOwnershipInterestsInSubsidiaries" contextRef="From20220101To20221231_StatutoryReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:ChangesInOwnershipInterestsInSubsidiaries" contextRef="From20220101To20221231_SpecialReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-es:ChangesInOwnershipInterestsInSubsidiaries" contextRef="From20220101To20221231_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">64,085</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-es:ChangesInOwnershipInterestsInSubsidiaries" contextRef="From20220101To20221231_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">64,085</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:ChangesInOwnershipInterestsInSubsidiaries" contextRef="From20220101To20221231_ReserveOfExchangeDifferencesOnTranslationMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:ChangesInOwnershipInterestsInSubsidiaries" contextRef="From20220101To20221231_OtherEquityInterestMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:ChangesInOwnershipInterestsInSubsidiaries" contextRef="From20220101To20221231_TreasurySharesMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-es:ChangesInOwnershipInterestsInSubsidiaries" contextRef="From20220101To20221231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">72,633</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:ChangesInOwnershipInterestsInSubsidiaries" contextRef="From20220101To20221231_NoncontrollingInterestsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">73,678</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:ChangesInOwnershipInterestsInSubsidiaries" contextRef="From20220101To20221231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,045</ix:nonFraction> </pre></td>
					</tr>
					<tr> 
						<td>N1</td> 
						<td> 
							<span class="zh">股份基礎給付</span> 
							<span class="en">　Share-based payments</span> 
						</td> 
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From20220101To20221231_OrdinaryShareMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From20220101To20221231_IssuedCapitalMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From20220101To20221231_CapitalReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,101</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From20220101To20221231_StatutoryReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From20220101To20221231_SpecialReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From20220101To20221231_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From20220101To20221231_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From20220101To20221231_ReserveOfExchangeDifferencesOnTranslationMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From20220101To20221231_OtherEquityInterestMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From20220101To20221231_TreasurySharesMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From20220101To20221231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,101</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From20220101To20221231_NoncontrollingInterestsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">5</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From20220101To20221231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,106</ix:nonFraction> </pre></td>
					</tr>
					<tr> 
						<td>Y1</td> 
						<td> 
							<span class="zh">權益增加(減少)總額</span> 
							<span class="en">　Total increase (decrease) in equity</span> 
						</td> 
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20220101To20221231_OrdinaryShareMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">146,060</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20220101To20221231_IssuedCapitalMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">146,060</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20220101To20221231_CapitalReserveMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">5,447</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20220101To20221231_StatutoryReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">207,182</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20220101To20221231_SpecialReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">12,489</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20220101To20221231_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">936,604</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20220101To20221231_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">716,933</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20220101To20221231_ReserveOfExchangeDifferencesOnTranslationMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">43,429</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20220101To20221231_OtherEquityInterestMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">43,429</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20220101To20221231_TreasurySharesMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20220101To20221231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">532,891</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20220101To20221231_NoncontrollingInterestsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">7,950</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20220101To20221231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">524,941</ix:nonFraction>)</pre></td>
					</tr>
					<tr> 
						<td>Z1</td> 
						<td> 
							<span class="zh">期末餘額</span> 
							<span class="en">　Equity at end of period</span> 
						</td> 
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20221231_OrdinaryShareMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">878,401</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20221231_IssuedCapitalMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">878,401</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20221231_CapitalReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,343,813</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20221231_StatutoryReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">207,182</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20221231_SpecialReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">12,489</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20221231_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,135,220</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20221231_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,354,891</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20221231_ReserveOfExchangeDifferencesOnTranslationMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">30,940</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20221231_OtherEquityInterestMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">30,940</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20221231_TreasurySharesMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">10,603</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20221231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,597,442</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20221231_NoncontrollingInterestsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">66,104</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20221231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,663,546</ix:nonFraction> </pre></td>
					</tr>
				</table> 
				<br /> 
			<!-- 去年同期權益變動表 -->
			<div class="rptidx"><span class="zh">單位：新臺幣仟元</span><span class="en">Unit: NT$ thousands</span></div> 
				<table style="width:150%"> 
					<tr> 
						<th colspan="32"> 
							<span class="zh">去年同期權益變動表</span><span class="en"> Last year's Statements of Change in Equity </span> 
						</th> 
					</tr> 
					<tr> 
						<th colspan='2' rowspan='2'></th> 
						<th>3110</th>
						<th>3100</th>
						<th>3200</th>
						<th>3310</th>
						<th>3320</th>
						<th>3350</th>
						<th>3300</th>
						<th>3410</th>
						<th>3400</th>
						<th>3500</th>
						<th>31XX</th>
						<th>36XX</th>
						<th>3XXX</th>
					</tr> 
					<tr> 
						<th> 
							<span class="zh">普通股股本</span> 
							<span class="en">　　　　　Ordinary share</span> 
						</th>
						<th> 
							<span class="zh">股本合計</span> 
							<span class="en">　　　　Total share capital</span> 
						</th>
						<th> 
							<span class="zh">資本公積</span> 
							<span class="en">　　　　Capital surplus</span> 
						</th>
						<th> 
							<span class="zh">法定盈餘公積</span> 
							<span class="en">　　　　　Legal reserve</span> 
						</th>
						<th> 
							<span class="zh">特別盈餘公積</span> 
							<span class="en">　　　　　Special reserve</span> 
						</th>
						<th> 
							<span class="zh">未分配盈餘（或待彌補虧損）</span> 
							<span class="en">　　　　　Unappropriated retained earnings (accumulated deficit)</span> 
						</th>
						<th> 
							<span class="zh">保留盈餘合計</span> 
							<span class="en">　　　　Total retained earnings</span> 
						</th>
						<th> 
							<span class="zh">國外營運機構財務報表換算之兌換差額</span> 
							<span class="en">　　　　　Exchange differences on translation of foreign financial statements</span> 
						</th>
						<th> 
							<span class="zh">其他權益項目合計</span> 
							<span class="en">　　　　Total other equity interest</span> 
						</th>
						<th> 
							<span class="zh">庫藏股票</span> 
							<span class="en">　　　　Treasury shares</span> 
						</th>
						<th> 
							<span class="zh">歸屬於母公司業主之權益總計</span> 
							<span class="en">　　　Total equity attributable to owners of parent</span> 
						</th>
						<th> 
							<span class="zh">非控制權益</span> 
							<span class="en">　　　Non-controlling interests</span> 
						</th>
						<th> 
							<span class="zh">權益總額</span> 
							<span class="en">　　Total equity</span> 
						</th>
					</tr> 
					<tr> 
						<td>A1</td> 
						<td> 
							<span class="zh">期初餘額</span> 
							<span class="en">　Equity at beginning of period</span> 
						</td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20210101_OrdinaryShareMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">665,032</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20210101_IssuedCapitalMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">665,032</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20210101_CapitalReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,933,081</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20210101_StatutoryReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20210101_SpecialReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20210101_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">525,912</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20210101_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">525,912</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20210101_ReserveOfExchangeDifferencesOnTranslationMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">6,681</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20210101_OtherEquityInterestMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">6,681</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20210101_TreasurySharesMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">20,478</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20210101_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,045,042</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20210101_NoncontrollingInterestsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">602,465</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20210101_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,647,507</ix:nonFraction> </pre></td>
					</tr>
					<tr> 
						<td>C11</td> 
						<td> 
							<span class="zh">資本公積彌補虧損</span> 
							<span class="en">　　Capital surplus used to offset accumulated deficits</span> 
						</td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:CapitalSurplusUsedToOffsetAccumulatedDeficits" contextRef="From20210101To20211231_OrdinaryShareMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:CapitalSurplusUsedToOffsetAccumulatedDeficits" contextRef="From20210101To20211231_IssuedCapitalMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-es:CapitalSurplusUsedToOffsetAccumulatedDeficits" contextRef="From20210101To20211231_CapitalReserveMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">525,912</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:CapitalSurplusUsedToOffsetAccumulatedDeficits" contextRef="From20210101To20211231_StatutoryReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:CapitalSurplusUsedToOffsetAccumulatedDeficits" contextRef="From20210101To20211231_SpecialReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:CapitalSurplusUsedToOffsetAccumulatedDeficits" contextRef="From20210101To20211231_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">525,912</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:CapitalSurplusUsedToOffsetAccumulatedDeficits" contextRef="From20210101To20211231_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">525,912</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:CapitalSurplusUsedToOffsetAccumulatedDeficits" contextRef="From20210101To20211231_ReserveOfExchangeDifferencesOnTranslationMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:CapitalSurplusUsedToOffsetAccumulatedDeficits" contextRef="From20210101To20211231_OtherEquityInterestMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:CapitalSurplusUsedToOffsetAccumulatedDeficits" contextRef="From20210101To20211231_TreasurySharesMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:CapitalSurplusUsedToOffsetAccumulatedDeficits" contextRef="From20210101To20211231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:CapitalSurplusUsedToOffsetAccumulatedDeficits" contextRef="From20210101To20211231_NoncontrollingInterestsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:CapitalSurplusUsedToOffsetAccumulatedDeficits" contextRef="From20210101To20211231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr>
					<tr> 
						<td>C17</td> 
						<td> 
							<span class="zh">其他資本公積變動數</span> 
							<span class="en">　　Other changes in capital surplus</span> 
						</td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:OtherChangesInCapitalSurplus" contextRef="From20210101To20211231_OrdinaryShareMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">66,159</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:OtherChangesInCapitalSurplus" contextRef="From20210101To20211231_IssuedCapitalMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">66,159</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-es:OtherChangesInCapitalSurplus" contextRef="From20210101To20211231_CapitalReserveMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">66,159</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:OtherChangesInCapitalSurplus" contextRef="From20210101To20211231_StatutoryReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:OtherChangesInCapitalSurplus" contextRef="From20210101To20211231_SpecialReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:OtherChangesInCapitalSurplus" contextRef="From20210101To20211231_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:OtherChangesInCapitalSurplus" contextRef="From20210101To20211231_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:OtherChangesInCapitalSurplus" contextRef="From20210101To20211231_ReserveOfExchangeDifferencesOnTranslationMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:OtherChangesInCapitalSurplus" contextRef="From20210101To20211231_OtherEquityInterestMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:OtherChangesInCapitalSurplus" contextRef="From20210101To20211231_TreasurySharesMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:OtherChangesInCapitalSurplus" contextRef="From20210101To20211231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:OtherChangesInCapitalSurplus" contextRef="From20210101To20211231_NoncontrollingInterestsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:OtherChangesInCapitalSurplus" contextRef="From20210101To20211231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr>
					<tr> 
						<td>D1</td> 
						<td> 
							<span class="zh">本期淨利（淨損）</span> 
							<span class="en">　Profit (loss)</span> 
						</td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From20210101To20211231_OrdinaryShareMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From20210101To20211231_IssuedCapitalMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From20210101To20211231_CapitalReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From20210101To20211231_StatutoryReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From20210101To20211231_SpecialReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From20210101To20211231_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,078,192</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From20210101To20211231_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,078,192</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From20210101To20211231_ReserveOfExchangeDifferencesOnTranslationMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From20210101To20211231_OtherEquityInterestMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From20210101To20211231_TreasurySharesMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From20210101To20211231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,078,192</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From20210101To20211231_NoncontrollingInterestsMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">46,746</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From20210101To20211231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,031,446</ix:nonFraction> </pre></td>
					</tr>
					<tr> 
						<td>D3</td> 
						<td> 
							<span class="zh">本期其他綜合損益</span> 
							<span class="en">　Other comprehensive income</span> 
						</td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20210101To20211231_OrdinaryShareMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20210101To20211231_IssuedCapitalMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20210101To20211231_CapitalReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20210101To20211231_StatutoryReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20210101To20211231_SpecialReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20210101To20211231_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20210101To20211231_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20210101To20211231_ReserveOfExchangeDifferencesOnTranslationMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">5,808</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20210101To20211231_OtherEquityInterestMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">5,808</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20210101To20211231_TreasurySharesMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20210101To20211231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">5,808</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20210101To20211231_NoncontrollingInterestsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,390</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20210101To20211231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">1,418</ix:nonFraction>)</pre></td>
					</tr>
					<tr> 
						<td>D5</td> 
						<td> 
							<span class="zh">本期綜合損益總額</span> 
							<span class="en">　Total comprehensive income</span> 
						</td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20210101To20211231_OrdinaryShareMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20210101To20211231_IssuedCapitalMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20210101To20211231_CapitalReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20210101To20211231_StatutoryReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20210101To20211231_SpecialReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20210101To20211231_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,078,192</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20210101To20211231_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,078,192</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20210101To20211231_ReserveOfExchangeDifferencesOnTranslationMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">5,808</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20210101To20211231_OtherEquityInterestMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">5,808</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20210101To20211231_TreasurySharesMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20210101To20211231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,072,384</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20210101To20211231_NoncontrollingInterestsMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">42,356</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20210101To20211231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,030,028</ix:nonFraction> </pre></td>
					</tr>
					<tr> 
						<td>M7</td> 
						<td> 
							<span class="zh">對子公司所有權權益變動</span> 
							<span class="en">　Changes in ownership interests in subsidiaries</span> 
						</td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:ChangesInOwnershipInterestsInSubsidiaries" contextRef="From20210101To20211231_OrdinaryShareMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:ChangesInOwnershipInterestsInSubsidiaries" contextRef="From20210101To20211231_IssuedCapitalMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:ChangesInOwnershipInterestsInSubsidiaries" contextRef="From20210101To20211231_CapitalReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,648</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:ChangesInOwnershipInterestsInSubsidiaries" contextRef="From20210101To20211231_StatutoryReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:ChangesInOwnershipInterestsInSubsidiaries" contextRef="From20210101To20211231_SpecialReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-es:ChangesInOwnershipInterestsInSubsidiaries" contextRef="From20210101To20211231_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">5,438</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-es:ChangesInOwnershipInterestsInSubsidiaries" contextRef="From20210101To20211231_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">5,438</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:ChangesInOwnershipInterestsInSubsidiaries" contextRef="From20210101To20211231_ReserveOfExchangeDifferencesOnTranslationMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:ChangesInOwnershipInterestsInSubsidiaries" contextRef="From20210101To20211231_OtherEquityInterestMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:ChangesInOwnershipInterestsInSubsidiaries" contextRef="From20210101To20211231_TreasurySharesMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-es:ChangesInOwnershipInterestsInSubsidiaries" contextRef="From20210101To20211231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">2,790</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-es:ChangesInOwnershipInterestsInSubsidiaries" contextRef="From20210101To20211231_NoncontrollingInterestsMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">502,305</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-es:ChangesInOwnershipInterestsInSubsidiaries" contextRef="From20210101To20211231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">505,095</ix:nonFraction>)</pre></td>
					</tr>
					<tr> 
						<td>N1</td> 
						<td> 
							<span class="zh">股份基礎給付</span> 
							<span class="en">　Share-based payments</span> 
						</td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From20210101To20211231_OrdinaryShareMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,150</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From20210101To20211231_IssuedCapitalMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,150</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From20210101To20211231_CapitalReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">5,602</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From20210101To20211231_StatutoryReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From20210101To20211231_SpecialReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From20210101To20211231_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">930</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From20210101To20211231_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">930</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From20210101To20211231_ReserveOfExchangeDifferencesOnTranslationMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From20210101To20211231_OtherEquityInterestMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From20210101To20211231_TreasurySharesMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">9,875</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From20210101To20211231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">15,697</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From20210101To20211231_NoncontrollingInterestsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">350</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From20210101To20211231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">16,047</ix:nonFraction> </pre></td>
					</tr>
					<tr> 
						<td>Y1</td> 
						<td> 
							<span class="zh">權益增加(減少)總額</span> 
							<span class="en">　Total increase (decrease) in equity</span> 
						</td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20210101To20211231_OrdinaryShareMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">67,309</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20210101To20211231_IssuedCapitalMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">67,309</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20210101To20211231_CapitalReserveMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">583,821</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20210101To20211231_StatutoryReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20210101To20211231_SpecialReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20210101To20211231_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,597,736</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20210101To20211231_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,597,736</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20210101To20211231_ReserveOfExchangeDifferencesOnTranslationMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">5,808</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20210101To20211231_OtherEquityInterestMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">5,808</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20210101To20211231_TreasurySharesMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">9,875</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20210101To20211231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,085,291</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20210101To20211231_NoncontrollingInterestsMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">544,311</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20210101To20211231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,540,980</ix:nonFraction> </pre></td>
					</tr>
					<tr> 
						<td>Z1</td> 
						<td> 
							<span class="zh">期末餘額</span> 
							<span class="en">　Equity at end of period</span> 
						</td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20211231_OrdinaryShareMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">732,341</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20211231_IssuedCapitalMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">732,341</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20211231_CapitalReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,349,260</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20211231_StatutoryReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20211231_SpecialReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20211231_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,071,824</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20211231_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,071,824</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20211231_ReserveOfExchangeDifferencesOnTranslationMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">12,489</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20211231_OtherEquityInterestMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">12,489</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20211231_TreasurySharesMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">10,603</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20211231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,130,333</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20211231_NoncontrollingInterestsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">58,154</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20211231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,188,487</ix:nonFraction> </pre></td>
					</tr>

				</table> 
				<br /> 
			<!-- 會計師查核報告 -->	
			<div id="ReportOfIndependentAuditors"></div> 
			<span class="zh">
			<div class="rptidx">單位：新臺幣仟元</div> 
				<table> 
					<tr>
						<th colspan="3">會計師查核（核閱）報告</th> 
					</tr> 
					<tr> 
						<th style="text-align:left;width:600px;">　 會計師事務所名稱</th> 
						<td colspan="2"><pre><ix:nonNumeric name="tifrs-ar:AccountantName" contextRef="AsOf20230223" xml:lang="zh" escape="true">資誠聯合會計師事務所</ix:nonNumeric></pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left;width:600px;">　 簽證會計師名稱 1</th> 
						<td colspan="2"><pre><ix:nonNumeric name="tifrs-ar:AssuranceAccountantName1" contextRef="AsOf20230223" xml:lang="zh" escape="true">周筱姿</ix:nonNumeric></pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left;width:600px;">　 簽證會計師名稱 2</th> 
						<td colspan="2"><pre><ix:nonNumeric name="tifrs-ar:AssuranceAccountantName2" contextRef="AsOf20230223" xml:lang="zh" escape="true">梁華玲</ix:nonNumeric></pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left;width:600px;">　 核閱或查核日期</th> 
						<td colspan="2"><pre><ix:nonNumeric name="tifrs-ar:ReviewAuditDate" contextRef="AsOf20230223" xml:lang="zh" escape="true">2023-02-23</ix:nonNumeric></pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left;width:600px;">　 報告類型</th> 
						<td colspan="2"></td>
					</tr> 
					<tr> 
						<th style="text-align:left;width:600px;">　　 查核報告</th> 
						<td colspan="2"><pre><ix:nonNumeric name="tifrs-ar:AuditReport" contextRef="AsOf20230223" xml:lang="zh" escape="true">Y</ix:nonNumeric></pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left;width:600px;">　 核閱或查核報告類型</th> 
						<td colspan="2"></td>
					</tr> 
					<tr> 
						<th style="text-align:left;width:600px;">　　 無保留意見/結論</th> 
						<td colspan="2"><pre><ix:nonNumeric name="tifrs-ar:UnqualifiedOpinionAbstract" contextRef="AsOf20230223" xml:lang="zh" escape="true">Y</ix:nonNumeric></pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left;width:600px;">　 報告類型細分</th> 
						<td colspan="2"></td>
					</tr> 
					<tr> 
						<th style="text-align:left;width:600px;">　 簡述強調事項內容</th> 
						<td colspan="2"></td>
					</tr> 
					<tr> 
						<th style="text-align:left;width:600px;">　 簡述其他事項內容</th> 
						<td colspan="2"></td>
					</tr> 
					<tr> 
						<th style="text-align:left;width:600px;">　 會計師查核(核閱)報告內容</th> 
						<td colspan="2"><pre class="note"><ix:nonNumeric name="tifrs-ar:AccountantsReportBody" contextRef="AsOf20230223" xml:lang="zh" escape="true">益安生醫股份有限公司  公鑒： 
    查核意見 
    益安生醫股份有限公司及子公司（以下簡稱「益安生醫集團」）民國111年及110年1 
2月31日之合併資產負債表，暨民國111年及110年1月1日至12月31日之合併綜合損益表、 
合併權益變動表、合併現金流量表，以及合併財務報表附註(包含重大會計政策彙總)， 
業經本會計師查核竣事。 
    依本會計師之意見，上開合併財務報表在所有重大方面係依照證券發行人財務報告 
編製準則暨經金融監督管理委員會認可並發布生效之國際財務報導準則、國際會計準則 
、解釋及解釋公告編製，足以允當表達益安生醫集團民國111年及110年12月31日之合併 
財務狀況，暨民國111年及110年1月1日至12月31日之合併財務績效及合併現金流量。 
    查核意見之基礎 
    本會計師係依照會計師查核簽證財務報表規則及中華民國審計準則執行查核工作。 
本會計師於該等準則下之責任將於會計師查核合併財務報表之責任段進一步說明。本會 
計師所隸屬事務所受獨立性規範之人員已依中華民國會計師職業道德規範，與益安生醫 
集團保持超然獨立，並履行該規範之其他責任。本會計師相信已取得足夠及適切之查核 
證據，以作為表示查核意見之基礎。 
    關鍵查核事項 
    關鍵查核事項係指依本會計師之專業判斷，對益安生醫集團民國111年度合併財務報 
表之查核最為重要之事項。該等事項已於查核合併財務報表整體及形成查核意見之過程 
中予以因應，本會計師並不對該等事項單獨表示意見。 
    益安生醫集團民國111年度合併財務報表之關鍵查核事項如下： 
    重大股權交易 
    事項說明 
    有關企業合併之會計政策請詳合併財務報告附註四(二十八)；會計項目之說明請詳
合併財務報告附註六(二十六)。      
    益安生醫集團於民國111年4月8日以美金7,878,512元購入Second Source Medical 
LLC 100%股權。前揭Second Source Medical LLC 之股權交易係採用國際會計準則第三
號「企業合併」之會計處理。因此項股權交易產生之可辨認無形資產公允價值之衡量係
以管理階層對Second Source Medical LLC 未來營運之預估與展望作為基礎，涉及管理
階層主觀判斷及重大估計，其衡量結果影響重大，故本會計師將該取得股權交易列為本
年度最為關注事項之一。
    因應之查核程序 
    本會計師對上開關鍵查核事項已執行之查核程序彙總說明如下: 
  1.與管理階層訪談以瞭解本次股權交易之目的、評估過程及對價決定之方式，並覆核 
董事會之會議記錄暨股權交易合約，確認相關決議事項與股權交易合約之內容一致。 
  2.評估管理當局所委任外部評價專家之適任性及客觀性，並覆核外部評價專家出具之 
收購價格分攤報告中可辨認無形資產之認列與衡量所採用原始資料主要假設之合理性。 
查核人員與查核人員所採用內部評價專家所執行之程序如下： 
    (1)覆核外部評價專家使用之評價方法與計算公式設定； 
    (2)覆核所使用之預計成長率及毛利率並與歷史結果比較； 
    (3)覆核所使用之折現率並與市場中類似資產報酬率比較； 
    (4)評估所辨識出無形資產之耐用年限衡量依據。 
  3.覆核本交易之會計處理及財務報表之表達與揭露。 
  4.檢視銀行對帳單以確認交易款項均付訖。 
    其他事項–個體財務報告 
    益安生醫股份有限公司已編製民國111年度及110年度個體財務報表，並經本會計師 
出具無保留意見之查核報告在案，備供參考。 
    管理階層與治理單位對合併財務報表之責任 
    管理階層之責任係依照證券發行人財務報告編製準則暨經金融監督管理委員會認可 
並發布生效之國際財務報導準則、國際會計準則、解釋及解釋公告編製允當表達之合併 
財務報表，且維持與合併財務報表編製有關之必要內部控制，以確保合併財務報表未存 
有導因於舞弊或錯誤之重大不實表達。 
    於編製合併財務報表時，管理階層之責任亦包括評估益安生醫集團繼續經營之能力 
、相關事項之揭露，以及繼續經營會計基礎之採用，除非管理階層意圖清算益安生醫集 
團或停止營業，或除清算或停業外別無實際可行之其他方案。 
    益安生醫集團之治理單位(含審計委員會)負有監督財務報導流程之責任。 
    會計師查核合併財務報表之責任 
    本會計師查核合併財務報表之目的，係對合併財務報表整體是否存有導因於舞弊或 
錯誤之重大不實表達取得合理確信，並出具查核報告。合理確信係高度確信，惟依照中 
華民國審計準則執行之查核工作無法保證必能偵出合併財務報表存有之重大不實表達。 
不實表達可能導因於舞弊或錯誤。如不實表達之個別金額或彙總數可合理預期將影響合 
併財務報表使用者所作之經濟決策，則被認為具有重大性。 
    本會計師依照中華民國審計準則查核時，運用專業判斷及專業懷疑。本會計師亦執 
行下列工作： 
    1.辨認並評估合併財務報表導因於舞弊或錯誤之重大不實表達風險；對所評估之風 
險設計及執行適當之因應對策；並取得足夠及適切之查核證據以作為查核意見之基礎。 
因舞弊可能涉及共謀、偽造、故意遺漏、不實聲明或踰越內部控制，故未偵出導因於舞 
弊之重大不實表達之風險高於導因於錯誤者。 
    2.對與查核攸關之內部控制取得必要之瞭解，以設計當時情況下適當之查核程序， 
惟其目的非對益安生醫集團內部控制之有效性表示意見。 
    3.評估管理階層所採用會計政策之適當性，及其所作會計估計與相關揭露之合理性 
。 
    4.依據所取得之查核證據，對管理階層採用繼續經營會計基礎之適當性，以及使益 
安生醫集團繼續經營之能力可能產生重大疑慮之事件或情況是否存在重大不確定性，作 
出結論。本會計師若認為該等事件或情況存在重大不確定性，則須於查核報告中提醒合 
併財務報表使用者注意合併財務報表之相關揭露，或於該等揭露係屬不適當時修正查核 
意見。本會計師之結論係以截至查核報告日所取得之查核證據為基礎。惟未來事件或情 
況可能導致益安生醫集團不再具有繼續經營之能力。 
    5.評估合併財務報表（包括相關附註）之整體表達、結構及內容，以及合併財務報 
表是否允當表達相關交易及事件。 
    6.對於集團內組成個體之財務資訊取得足夠及適切之查核證據，以對合併財務報表 
表示意見。本會計師負責集團查核案件之指導、監督及執行，並負責形成集團查核意見 
。 
    本會計師與治理單位溝通之事項，包括所規劃之查核範圍及時間，以及重大查核發 
現（包括於查核過程中所辨認之內部控制顯著缺失）。 
    本會計師亦向治理單位提供本會計師所隸屬事務所受獨立性規範之人員已遵循中華 
民國會計師職業道德規範中有關獨立性之聲明，並與治理單位溝通所有可能被認為會影 
響會計師獨立性之關係及其他事項（包括相關防護措施）。 
     
    本會計師從與治理單位溝通之事項中，決定對益安生醫集團民國111年度合併財務報 
表查核之關鍵查核事項。本會計師於查核報告中敘明該等事項，除非法令不允許公開揭 
露特定事項，或在極罕見情況下，本會計師決定不於查核報告中溝通特定事項，因可合 
理預期此溝通所產生之負面影響大於所增進之公眾利益。 
     
                                      
                                      
                                      
                                     資誠聯合會計師事務所  
                                      
                                               周筱姿 
                                     會計師           
                                               梁華玲 
                                      
                                     前財政部證券管理委員會 
                                     核准簽證文號：(85)台財證(六)第68700號 
                                     前財政部證券暨期貨管理委員會 
                                     核准簽證文號：(86)台財證(六)第83253號 
                                     中華民國112年2月23日

</ix:nonNumeric></pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left" colspan="2">　 截至本季止採用其他會計師查核意見(核閱報告)之子公司期末資產總額</th> 
						<td class="amt" style="width:100px"><pre><ix:nonFraction name="tifrs-ar:EndingBalanceOfAssetsOfSubsidiariesWhoseFinancialStatementsWereAuditedOrReviewedByOtherIndependentAccountants" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD" xml:lang="zh">0</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left" colspan="2">　 截至本季止採用其他會計師查核意見(核閱報告)之子公司營業收入淨額</th> 
						<td class="amt" style="width:100px"><pre><ix:nonFraction name="tifrs-ar:TotalYearToDateRevenuesOfSubsidiariesWhoseFinancialStatementsWereAuditedOrReviewedByOtherIndependentAccountants" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD" xml:lang="zh">0</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left" colspan="2">　 截至本季止採用其他會計師查核意見(核閱報告)之採用權益法之投資期末餘額</th> 
						<td class="amt" style="width:100px"><pre><ix:nonFraction name="tifrs-ar:EndingBalanceOfInvestmentsAccountedForUsingEquityMethodWhoseFinancialStatementsWereAuditedOrReviewedByOtherIndependentAccountants" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD" xml:lang="zh">0</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left" colspan="2">　 截至本季止採用其他會計師查核意見(核閱報告)之採用權益法之投資當期認列關聯企業及合資損益之份額</th> 
						<td class="amt" style="width:100px"><pre><ix:nonFraction name="tifrs-ar:ShareOfProfitLossForTheQuarterOfAssociatesAndJointVenturesAccountedForUsingEquityMethodWhoseFinancialStatementsWereAuditedOrReviewedByOtherIndependentAccountants" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD" xml:lang="zh">0</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left" colspan="2">　 截至本季止未經會計師查核(核閱)之子公司期末資產總額</th> 
						<td class="amt" style="width:100px"><pre><ix:nonFraction name="tifrs-ar:EndingBalanceOfAssetsOfSubsidiariesWhoseFinancialStatementsWereOnUnauditedOrUnreviewed" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD" xml:lang="zh">0</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left" colspan="2">　 截至本季止未經會計師查核(核閱)之子公司綜合損益金額</th> 
						<td class="amt" style="width:100px"><pre><ix:nonFraction name="tifrs-ar:YearToDateComprehensiveIncomeOfSubsidiariesWhoseFinancialStatementsWereUnauditedOrUnreviewed" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD" xml:lang="zh">0</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left" colspan="2">　 截至本季止未經會計師查核(核閱)之採用權益法之投資期末餘額</th> 
						<td class="amt" style="width:100px"><pre><ix:nonFraction name="tifrs-ar:EndingBalanceOfInvestmentsAccountedForUsingEquityMethodWhoseFinancialStatementsWereUnauditedOrUnreviewed" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD" xml:lang="zh">0</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left" colspan="2">　 截至本季止未經會計師查核(核閱)之採用權益法之投資當期認列關聯企業及合資損益之份額</th> 
						<td class="amt" style="width:100px"><pre><ix:nonFraction name="tifrs-ar:ShareOfYearToDateProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethodWhoseFinancialStatementsWereUnauditedOrUnreviewed" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD" xml:lang="zh">0</ix:nonFraction> </pre></td>
					</tr> 
				</table>
			</span>
			<div id="ReportOfIndependentAuditorsEN"></div> 
			<span class="en">
			<div class="rptidx">Unit: NT$ thousands</div> 
				<table> 
					<tr>
						<th colspan="3">Independent Auditors' (Review) Report</th> 
					</tr> 
					<tr> 
						<th style="text-align:left;width:600px;">　 Name of CPA Firm</th> 
						<td colspan="2"><pre><ix:nonNumeric name="tifrs-ar:AccountantName" contextRef="AsOf20230223" xml:lang="en" escape="true">PricewaterhouseCoopers</ix:nonNumeric></pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left;width:600px;">　 Name of CPA 1</th> 
						<td colspan="2"><pre><ix:nonNumeric name="tifrs-ar:AssuranceAccountantName1" contextRef="AsOf20230223" xml:lang="en" escape="true">Chou, Hsiao-Tzu</ix:nonNumeric></pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left;width:600px;">　 Name of CPA 2</th> 
						<td colspan="2"><pre><ix:nonNumeric name="tifrs-ar:AssuranceAccountantName2" contextRef="AsOf20230223" xml:lang="en" escape="true">Liang, Hua-Ling</ix:nonNumeric></pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left;width:600px;">　 Date of Audit (Review)</th> 
						<td colspan="2"><pre><ix:nonNumeric name="tifrs-ar:ReviewAuditDate" contextRef="AsOf20230223" xml:lang="en" escape="true">2023-02-23</ix:nonNumeric></pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left;width:600px;">　 Type of Report</th> 
						<td colspan="2"></td>
					</tr> 
					<tr> 
						<th style="text-align:left;width:600px;">　　 Audit Report</th> 
						<td colspan="2"><pre><ix:nonNumeric name="tifrs-ar:AuditReport" contextRef="AsOf20230223" xml:lang="en" escape="true">Y</ix:nonNumeric></pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left;width:600px;">　 Type of Opinion</th> 
						<td colspan="2"></td>
					</tr> 
					<tr> 
						<th style="text-align:left;width:600px;">　　 Unqualified Opinion or Conclusion</th> 
						<td colspan="2"><pre><ix:nonNumeric name="tifrs-ar:UnqualifiedOpinionAbstract" contextRef="AsOf20230223" xml:lang="en" escape="true">Y</ix:nonNumeric></pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left;width:600px;">　 Situations for not Issuing a Standard Unqualified Opinion or Conclusion</th> 
						<td colspan="2"></td>
					</tr> 
					<tr> 
						<th style="text-align:left;width:600px;">　 Description of Matter Emphasized</th> 
						<td colspan="2"></td>
					</tr> 
					<tr> 
						<th style="text-align:left;width:600px;">　 Description of Other Matter</th> 
						<td colspan="2"></td>
					</tr> 
					<tr> 
						<th style="text-align:left;width:600px;">　 Content of Independent Auditors Report</th> 
						<td colspan="2"><pre><ix:nonNumeric name="tifrs-ar:AccountantsReportBody" contextRef="AsOf20230223" xml:lang="en" escape="true">To the Board of Directors and Shareholders of MEDEON BIODESIGN 
, INC. 
     
    Opinion 
    We have audited the accompanying consolidated balance sheets of MEDEON BI 
ODESIGN, INC. AND SUBSIDIARIES (the “Group”) as at December 31, 2022 and 20 
21, and the related consolidated statements of comprehensive income, of chang 
es in equity and of cash flows for the years then ended, and notes to the con 
solidated financial statements, including a summary of significant accounting 
 policies. 
     
    In our opinion, the accompanying consolidated financial statements presen 
t fairly, in all material respects, the consolidated financial position of th 
e Group as at December 31, 2022 and 2021, and its consolidated financial perf 
ormance and its consolidated cash flows for the years then ended in accordanc 
e with the Regulations Governing the Preparation of Financial Reports by Secu 
rities Issuers and the International Financial Reporting Standards, Internati 
onal Accounting Standards, IFRIC Interpretations, and SIC Interpretations as  
endorsed by the Financial Supervisory Commission. 
     
    Basis for opinion 
    We conducted our audits in accordance with the Regulations Governing Audi 
ting and Attestation of Financial Statements by Certified Public Accountants  
and generally accepted auditing standards in the Republic of China. Our respo 
nsibilities under those standards are further described in the Auditor’s Res 
ponsibilities for the Audit of the Consolidated Financial Statements section  
of our report. We are independent of the Group in accordance with the Norm of 
 Professional Ethics for Certified Public Accountants of the Republic of Chin 
a, and we have fulfilled our other ethical responsibilities in accordance wit 
h these requirements. We believe that the audit evidence we have obtained is  
sufficient and appropriate to provide a basis for our opinion. 
     
    Key audit matters 
    Key audit matters are those matters that, in our professional judgement,  
were of most significance in our audit of the Group’s 2022 consolidated fina 
ncial statements. These matters were addressed in the context of our audit of 
 the consolidated financial statements as a whole and, in forming our opinion 
 thereon, we do not provide a separate opinion on these matters. 
    Key audit matters for the Group’s 2022 consolidated financial statements 
 are stated as follows: 
     
    Disposal of significant equity transaction 
    Description 
    For a description of the accounting policy for investments accounted for  
using equity method, please refer to Note 4(3); and for the information of in 
vestments accounted for using equity method, please refer to Note 6(6). 
    As described in Note 6(6), Medeon Biodesign, Inc. had disposed equity int 
erest in Delta Asia International Corporation held to ___%, which had lost th 
e control of Delta Asia International Corporation. Medeon Biodesign, Inc. rec 
ognized gains on disposals of investment in the amount of TWD___ thousands. F 
or the disposal of equity interest in Delta Asia International Corporation, I 
FRS 10 was adopted for the above transaction. Since the gains on the disposal 
 was significant to the financial statements, we determined the profit or los 
s on disposal of subsidiary as a key audit matter. 
    How our audit addressed the matter 
    We performed the following audit procedures in respect of the above key a 
udit matter: 
    Interviewed with the management and confirmed the record of the Board mee 
ting related to the evaluation process and determination of price. 
    Reviewed related documents of the transactions to confirm that the intern 
al control procedure adopted by Medeon Biodesign, Inc. and “Regulations Gove 
rning the Acquisition and Disposal of Assets by Public Companies” have been  
followed. 
    Confirmed the calculation and the amount to be recognised is consistent w 
ith its policy. 
    Reviewed the bank statement and confirmed that payment of the disposal ha 
s been transferred. 
     
    Other matter – Parent company only financial statements 
    We have audited and expressed an unmodified opinion on the parent company 
 only financial statements of Medeon Biodesign, Inc. as at and for the years  
ended December 31, 2022 and 2021. 
     
    Responsibilities of management and those charged with governance for the  
consolidated financial statements 
    Management is responsible for the preparation and fair presentation of th 
e consolidated financial statements in accordance with the Regulations Govern 
ing the Preparation of Financial Reports by Securities Issuers and the Intern 
ational Financial Reporting Standards, International Accounting Standards, IF 
RIC Interpretations, and SIC Interpretations as endorsed by the Financial Sup 
ervisory Commission, and for such internal control as management determines i 
s necessary to enable the preparation of consolidated financial statements th 
at are free from material misstatement, whether due to fraud or error. 
     
    In preparing the consolidated financial statements, management is respons 
ible for assessing the Group’s ability to continue as a going concern, discl 
osing, as applicable, matters related to going concern and using the going co 
ncern basis of accounting unless management either intends to liquidate the G 
roup or to cease operations, or has no realistic alternative but to do so.  
     
    Those charged with governance, including Audit Committee, are responsible 
 for overseeing the Group’s financial reporting process. 
     
    Auditors’ responsibilities for the audit of the consolidated financial s 
tatements 
    Our objectives are to obtain reasonable assurance about whether the conso 
lidated financial statements as a whole are free from material misstatement,  
whether due to fraud or error, and to issue an auditors’ report that include 
s our opinion. Reasonable assurance is a high level of assurance, but is not  
a guarantee that an audit conducted in accordance with the generally accepted 
 auditing standards in the Republic of China will always detect a material mi 
sstatement when it exists. Misstatements can arise from fraud or error and ar 
e considered material if, individually or in the aggregate, they could reason 
ably be expected to influence the economic decisions of users taken on the ba 
sis of these consolidated financial statements.  
    As part of an audit in accordance with the generally accepted auditing st 
andards in the Republic of China, we exercise professional judgment and maint 
ain professional skepticism throughout the audit. We also: 
    Identify and assess the risks of material misstatement of the consolidate 
d financial statements, whether due to fraud or error, design and perform aud 
it procedures responsive to those risks, and obtain audit evidence that is su 
fficient and appropriate to provide a basis for our opinion. The risk of not  
detecting a material misstatement resulting from fraud is higher than for one 
 resulting from error, as fraud may involve collusion, forgery, intentional o 
missions, misrepresentations, or the override of internal control.  
    Obtain an understanding of internal control relevant to the audit in orde 
r to design audit procedures that are appropriate in the circumstances, but n 
ot for the purpose of expressing an opinion on the effectiveness of the Group 
’s internal control.  
    Evaluate the appropriateness of accounting policies used and the reasonab 
leness of accounting estimates and related disclosures made by management.  
    Conclude on the appropriateness of management’s use of the going concern 
 basis of accounting and, based on the audit evidence obtained, whether a mat 
erial uncertainty exists related to events or conditions that may cast signif 
icant doubt on the Group’s ability to continue as a going concern. If we con 
clude that a material uncertainty exists, we are required to draw attention i 
n our auditors’ report to the related disclosures in the consolidated financ 
ial statements or, if such disclosures are inadequate, to modify our opinion. 
 Our conclusions are based on the audit evidence obtained up to the date of o 
ur auditors’ report. However, future events or conditions may cause the Grou 
p to cease to continue as a going concern. 
    Evaluate the overall presentation, structure and content of the consolida 
ted financial statements, including the disclosures, and whether the consolid 
ated financial statements represent the underlying transactions and events in 
 a manner that achieves fair presentation. 
    Obtain sufficient appropriate audit evidence regarding the financial info 
rmation of the entities or business activities within the Group to express an 
 opinion on the consolidated financial statements. We are responsible for the 
 direction, supervision and performance of the group audit. We remain solely  
responsible for our audit opinion. 
     
    We communicate with those charged with governance regarding, among other  
matters, the planned scope and timing of the audit and significant audit find 
ings, including any significant deficiencies in internal control that we iden 
tify during our audit.  
    We also provide those charged with governance with a statement that we ha 
ve complied with relevant ethical requirements regarding independence, and to 
 communicate with them all relationships and other matters that may reasonabl 
y be thought to bear on our independence, and where applicable, related safeg 
uards.  
     
     
    From the matters communicated with those charged with governance, we dete 
rmine those matters that were of most significance in the audit of the consol 
idated financial statements of the current period and are therefore the key a 
udit matters. We describe these matters in our auditors’ report unless law o 
r regulation precludes public disclosure about the matter or when, in extreme 
ly rare circumstances, we determine that a matter should not be communicated  
in our report because the adverse consequences of doing so would reasonably b 
e expected to outweigh the public interest benefits of such communication. 
     
                                      
                                      
                                      
                                     Chou, Hsiao-Tzu 
                                      
                                     Liang, Hua-Ling 
                                      
                                     For and on Behalf of PricewaterhouseCoopers, Taiwan 
                                     March ___, 2023</ix:nonNumeric></pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left" colspan="2">　 Ending balance of assets of subsidiaries whose financial statements were audited or reviewed by other independent accountants</th> 
						<td class="amt" style="width:100px"><pre><ix:nonFraction name="tifrs-ar:EndingBalanceOfAssetsOfSubsidiariesWhoseFinancialStatementsWereAuditedOrReviewedByOtherIndependentAccountants" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD" xml:lang="en">0</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left" colspan="2">　 Total year-to-date revenues of subsidiaries whose financial statements were audited or reviewed by other independent accountants</th> 
						<td class="amt" style="width:100px"><pre><ix:nonFraction name="tifrs-ar:TotalYearToDateRevenuesOfSubsidiariesWhoseFinancialStatementsWereAuditedOrReviewedByOtherIndependentAccountants" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD" xml:lang="en">0</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left" colspan="2">　 Ending balance of investments accounted for using equity method whose financial statements were audited or reviewed by other independent accountants</th> 
						<td class="amt" style="width:100px"><pre><ix:nonFraction name="tifrs-ar:EndingBalanceOfInvestmentsAccountedForUsingEquityMethodWhoseFinancialStatementsWereAuditedOrReviewedByOtherIndependentAccountants" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD" xml:lang="en">0</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left" colspan="2">　 Share of year-to-date profit (loss) of associates and joint ventures accounted for using equity method which audited by other independent accountants</th> 
						<td class="amt" style="width:100px"><pre><ix:nonFraction name="tifrs-ar:ShareOfProfitLossForTheQuarterOfAssociatesAndJointVenturesAccountedForUsingEquityMethodWhoseFinancialStatementsWereAuditedOrReviewedByOtherIndependentAccountants" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD" xml:lang="en">0</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left" colspan="2">　 Ending balance of assets of subsidiaries whose financial statements were on unaudited or unreviewed</th> 
						<td class="amt" style="width:100px"><pre><ix:nonFraction name="tifrs-ar:EndingBalanceOfAssetsOfSubsidiariesWhoseFinancialStatementsWereOnUnauditedOrUnreviewed" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD" xml:lang="en">0</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left" colspan="2">　 Year-to-date comprehensive income of subsidiaries whose financial statements were unaudited or unreviewed</th> 
						<td class="amt" style="width:100px"><pre><ix:nonFraction name="tifrs-ar:YearToDateComprehensiveIncomeOfSubsidiariesWhoseFinancialStatementsWereUnauditedOrUnreviewed" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD" xml:lang="en">0</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left" colspan="2">　 Ending balance of investments accounted for using equity method whose financial statements were unaudited or unreviewed</th> 
						<td class="amt" style="width:100px"><pre><ix:nonFraction name="tifrs-ar:EndingBalanceOfInvestmentsAccountedForUsingEquityMethodWhoseFinancialStatementsWereUnauditedOrUnreviewed" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD" xml:lang="en">0</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left" colspan="2">　 Share of year-to-date profit (loss) of associates and joint ventures accounted for using equity method whose financial statements were unaudited or unreviewed</th> 
						<td class="amt" style="width:100px"><pre><ix:nonFraction name="tifrs-ar:ShareOfYearToDateProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethodWhoseFinancialStatementsWereUnauditedOrUnreviewed" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD" xml:lang="en">0</ix:nonFraction> </pre></td>
					</tr> 
				</table>
			</span>
			<br />
			<span class="zh">
			<div class="title">財務報表附註</div>
			<div id="HistoryAndOrganization">
				<table style="width:90%">
					<tr>
						<th colspan='5' style="text-align:left">公司沿革及業務範圍</th>
					</tr> 
					<tr>
						<td>　 公司沿革及業務範圍</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:HistoryAndOrganization" contextRef="From20220101To20221231" escape="true">

　　益安生醫股份有限公司(以下簡稱「本公司」)於民國101年12月22日經經濟部核准設立，
　　本公司及子公司（以下統稱「本集團」）主要營業項目為微創醫療器材研發及醫療器材之
　　製造暨銷售業務。本公司股票自民國105年7月起於財團法人中華民國證券櫃檯買賣中心買
　　賣。






</ix:nonNumeric></pre></td>
					</tr>
				</table>
			</div>
			<br />
			<div id="DateAndProceduresOfAuthorisationForIssueOfFinancialStatements">
				<table style="width:90%">
					<tr>
						<th colspan='5' style="text-align:left">通過財報之日期及程序</th>
					</tr> 
					<tr>
						<td>　 通過財報之日期及程序</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:DateAndProceduresOfAuthorisationForIssueOfFinancialStatements" contextRef="From20220101To20221231" escape="true">

　　本合併財務報告已於民國112年2月23日經董事會通過後發布。






</ix:nonNumeric></pre></td>
					</tr>
				</table>
			</div>
			<br />
			<div id="ApplicationOfNewlyIssuedOrAmendedStandardsAndInterpretations">
				<table style="width:90%">
					<tr>
						<th colspan='5' style="text-align:left">新發布及修訂準則及解釋之適用</th>
					</tr> 
					<tr>
						<td>　 新發布及修訂準則及解釋之適用</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:ApplicationOfNewlyIssuedOrAmendedStandardsAndInterpretations" contextRef="From20220101To20221231" escape="true">

　　(一)已採用金融監督管理委員會(以下簡稱「金管會」)認可並發布生效之新發布、修正後
　　　　國際財務報導準則之影響
　　　　下表彙列金管會認可並發布生效之民國111年適用之國際財務報導準則之新發布、修正
　　　　及修訂之準則及解釋：

                 新發布/修正/修訂準則及解釋              國際會計準則理事會發布之生效日  
      ------------------------------------------------  ---------------------------------
      國際財務報導準則第3號之修正「對觀念架構之索引」            民國111年1月1日         
      國際會計準則第16號之修正「不動產、廠房及設備：達           民國111年1月1日         
      到預定使用狀態前之價款」                                                           
      國際會計準則第37號之修正「虧損性合約─履行合約之           民國111年1月1日         
      成本」                                                                             
      2018-2020週期之年度改善                                    民國111年1月1日         

　　　　本集團經評估上述準則及解釋對本集團財務狀況與財務績效並無重大影響。
　　(二)尚未採用金管會認可之新發布、修正後國際財務報導準則之影響
　　　　下表彙列金管會認可之民國112年適用之國際財務報導準則之新發布、修正及修訂之準
　　　　則及解釋：

                 新發布/修正/修訂準則及解釋              國際會計準則理事會發布之生效日  
      ------------------------------------------------  ---------------------------------
      國際會計準則第1號之修正「會計政策之揭露」                  民國112年1月1日         
      國際會計準則第8號之修正「會計估計之定義」                  民國112年1月1日         
      國際會計準則第12號之修正「與單一交易所產生之資產           民國112年1月1日         
      及負債有關之遞延所得稅」                                                           

　　　　本集團經評估上述準則及解釋對本集團財務狀況與財務績效並無重大影響。
　　(三)國際會計準則理事會已發布但尚未經金管會認可之國際財務報導準則之影響
　　　　下表彙列國際會計準則理事會已發布但尚未納入金管會認可之國際財務報導準則之新發
　　　　布、修正及修訂之準則及解釋：

                 新發布/修正/修訂準則及解釋              國際會計準則理事會發布之生效日  
      ------------------------------------------------  ---------------------------------
      國際財務報導準則第10號及國際會計準則第28號之修正      待國際會計準則理事會決定     
      「投資者與其關聯企業或合資間之資產出售或投入」                                     
      國際財務報導準則第16號之修正「售後租回中之租賃負           民國113年1月1日         
      債」                                                                               
      國際財務報導準則第17號「保險合約」                         民國112年1月1日         
      國際財務報導準則第17號「保險合約」之修正                   民國112年1月1日         
      國際財務報導準則第17號之修正「初次適用國際財務報           民國112年1月1日         
      導準則第17號及國際財務報導準則第9號—比較資訊」                                    
      國際會計準則第1號之修正「負債之流動或非流動分類」          民國113年1月1日                                                                                          
      國際會計準則第1號之修正「具合約條款之非流動負債」          民國113年1月1日                                                                                          

　　　　本集團經評估上述準則及解釋對本集團財務狀況與財務績效並無重大影響。






</ix:nonNumeric></pre></td>
					</tr>
				</table>
			</div>
			<br />
			<div id="SummaryOfSignificantAccountingPolicies">
				<table style="width:90%">
					<tr>
						<th colspan='5' style="text-align:left">重大會計政策之彙總說明</th>
					</tr> 
					<tr>
						<td>　 遵循聲明</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:StatementOfIFRSAndRelatedRegulationsCompliance" contextRef="From20220101To20221231" escape="true">

　　　　本合併財務報告係依據證券發行人財務報告編製準則與金管會認可之國際財務報導準則
　　　　、國際會計準則、解釋及解釋公告(以下簡稱IFRSs)編製。






</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　 編製基礎</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:BasisOfPreparation" contextRef="From20220101To20221231" escape="true">

　　　　1.除下列重要項目外，本合併財務報告係按歷史成本編製：
　　　　　按公允價值衡量之透過損益按公允價值衡量之金融資產。
　　　　2.編製符合IFRSs之財務報告需要使用一些重要會計估計，在應用本集團的會計政策過
　　　　　程中亦需要管理階層運用其判斷，涉及高度判斷或複雜性之項目，或涉及合併財務報
　　　　　告之重大假設及估計之項目，請詳附註五說明。






</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　　 合併報表編製原則</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:PrinciplesOfConsolidation" contextRef="From20220101To20221231" escape="true">

          (1)本集團將所有子公司納入合併財務報告編製之個體。子公司指受本集團控制之個體
　　　　　　　（包括結構型個體），當本集團暴露於來自對該個體之參與之變動報酬或對該等變
　　　　　　　動報酬享有權利，且透過對該個體之權力有能力影響該等報酬時，本集團即控制該
　　　　　　　個體。子公司自本集團取得控制之日起納入合併財務報告，於喪失控制之日起終止
　　　　　　　合併。
　　　　　(2)集團內公司間之交易、餘額及未實現損益業已銷除。子公司之會計政策已作必要之
　　　　　　　調整，與本集團採用之政策一致。
　　　　　(3)損益及其他綜合損益各組成部分歸屬於母公司業主及非控制權益；綜合損益總額亦
　　　　　　　歸屬於母公司業主及非控制權益，即使因而導致非控制權益發生虧損餘額。
　　　　　(4)對子公司持股之變動若未導致喪失控制（與非控制權益之交易），係作為權益交易
　　　　　　　處理，亦即視為與業主間進行之交易。非控制權益之調整金額與所支付或收取對價
　　　　　　　之公允價值間之差額係直接認列於權益。
　　　　　(5)當集團喪失對子公司之控制，對前子公司之剩餘投資係按公允價值重新衡量，並作
　　　　　　　為原始認列金融資產之公允價值或原始認列投資關聯企業或合資之成本，公允價值
　　　　　　　與帳面金額之差額認列為當期損益。對於先前認列於其他綜合損益與該子公司有關
　　　　　　　之所有金額，其會計處理與本集團若直接處分相關資產或負債之基礎相同，亦即如
　　　　　　　先前認列為其他綜合損益之利益或損失，於處分相關資產或負債時將被重分類為損
　　　　　　　益，則當喪失對子公司之控制時，將該利益或損失自權益重分類為損益。




</ix:nonNumeric></pre></td>
					</tr>
				</table>
				<br /> 
				<table style="width:90%"> 
					<tr> 
						<th colspan='30' rowspan='1' style="text-align:left">列入合併財務報表之子公司</th> 
					</tr>
					<tr> 
						<th colspan='1' rowspan='2' style="text-align:center">投資公司名稱</th> 
						<th colspan='1' rowspan='2' style="text-align:center">子公司名稱</th> 
						<th colspan='1' rowspan='2' style="text-align:center">業務性質</th> 
						<th colspan='2' rowspan='1' style="text-align:center">所持股權百分比</th> 
						<th colspan='1' rowspan='2' style="text-align:center">說明</th> 
					</tr>
					<tr> 
						<th colspan='1' rowspan='1' style="text-align:center">本期</th> 
						<th colspan='1' rowspan='1' style="text-align:center">去年同期</th> 
					</tr>
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">益安生醫股份有限公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20220101To20221231" escape="true">MedeonBio,Inc.</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20220101To20221231" escape="true">醫療器材製造及研發</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.00</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20220101To20221231" escape="true">註5</ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">益安生醫股份有限公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20220101To20221231" escape="true">Medeon International,Inc.</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20220101To20221231" escape="true">投資及貿易業務</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20220101To20221231" escape="true">註1</ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">益安生醫股份有限公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20220101To20221231" escape="true">達亞國際股份有限公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20220101To20221231" escape="true">醫療零件製造及銷售</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.00</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.00</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20220101To20221231" escape="true">註3</ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">益安生醫股份有限公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20220101To20221231" escape="true">意能生技股份有限公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20220101To20221231" escape="true">醫療器材製造及研發</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">85.05</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">80.10</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20220101To20221231" escape="true">註4</ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">益安生醫股份有限公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20220101To20221231" escape="true">益創生醫股份有限公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20220101To20221231" escape="true">醫療器材銷售</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20220101To20221231" escape="true">-</ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">益安生醫股份有限公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20220101To20221231" escape="true">益興生醫股份有限公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20220101To20221231" escape="true">醫療器材製造及銷售</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">94.49</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">80.00</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20220101To20221231" escape="true">註7</ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">Medeon International,Inc.</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20220101To20221231" escape="true">Panther Orthopedics,Inc.</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20220101To20221231" escape="true">醫療器材製造及研發</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.00</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">68.05</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20220101To20221231" escape="true">註1及註9</ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">Medeon International,Inc.</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20220101To20221231" escape="true">Aquedeon Medical,Inc.</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20220101To20221231" escape="true">醫療器材製造及研發</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">97.14</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">97.14</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20220101To20221231" escape="true">註1</ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">Medeon International,Inc.</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20220101To20221231" escape="true">Jaguar Orthopedics,Inc.</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20220101To20221231" escape="true">醫療器材製造及研發</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.00</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.00</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20220101To20221231" escape="true">註2</ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">意能生技股份有限公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20220101To20221231" escape="true">Prodeon Medical,Inc.</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20220101To20221231" escape="true">醫療器材製造及研發</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20220101To20221231" escape="true">註6</ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">益興生醫股份有限公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20220101To20221231" escape="true">MedeonBio,Inc.</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20220101To20221231" escape="true">醫療器材製造及銷售</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.00</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20220101To20221231" escape="true">註5</ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">益興生醫股份有限公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20220101To20221231" escape="true">MediBalloon,Inc.</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20220101To20221231" escape="true">醫療器材製造及銷售</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20220101To20221231" escape="true">註7</ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">益興生醫股份有限公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20220101To20221231" escape="true">Second Source Medical LLC</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20220101To20221231" escape="true">醫療器材製造及銷售</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.00</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20220101To20221231" escape="true">註8</ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<th style="text-align:left" colspan='1'>備註</th>
						<td colspan='7' style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:Note-TheConsolidatedEntities" contextRef="From20220101To20221231" escape="true">註1:本公司於民國110年6月現金增資Medeon International,Inc.，並經由該子公司參與Panther Orthopedics,Inc.之特別股C之現金增資美金999,999元，持股比率增加至68.05%；
    另本公司於民國110年9月、11月現金增資Medeon International,Inc.，並經由該子公司參與Aquedeon Medical, Inc.之特別股D之現金增資美金6,000,000元，持股比率增加至97.14%；
    本公司於民國111年4月對Medeon International,Inc. 現金增資共計美金1,030,000元。
註2:Jaguar Orthopedics,Inc.係由Panther Orthopedics,Inc.分割設立，由Medeon International,Inc.持有50%股權；於民國110年8月解散清算。
註3:本公司於民國110年3月出售達亞國際股份有限公司部份股權，總價款為$86,136，持股比率減少至50.75%；於民國110年6月出售達亞國際股份有限公司部份股權，持股比率減少至33.40%，
    致本集團喪失對該子公司之控制，出售價款為$1,016,809，並依處分時之收盤價重新評價未出售之股權，帳列權益法投資$2,192,873，處分投資利益計$700,128，評價利益計$1,859,045，
    該利益認列於綜合損益表「停業單位利益」項目中，與該子公司相關之現金流量資訊，請詳附註六(二十七)現金流量補充資訊。
註4:本公司認購意能生技股份有限公司於民國110年9月發行甲種特別股3,685,000股，總價款為$280,060，本公司持股比例上升至80.1%；
    本公司續認購意能生技股份有限公司於民國111年3月發行乙種特別股4,935,000股，總價款為$394,800，本公司持股比例上升至85.05%。
註5:本公司於民國110年3月參與MedeonBio,Inc.之現金增資美金2,000,000元，並全額認購；
    本公司於民國111年5月將該子公司MedeonBio,Inc.股份以美金3,334,757.19元出售予另一家子公司益興生醫股份有限公司。
註6:意能生技股份有限公司於民國110年7月出資設立Prodeon Medical, Inc.，並現金增資美金3,000,000元。
註7:本公司於民國110年12月以$140,000參與益興生醫股份有限公司之現金增資取得80%股權，經評估取得控制力，並自該日起新增併入合併個體，請詳附註六(二十六)說明。
    本公司另於民國111年4月對益興生醫股份有限公司現金增資計$460,000，持股比例上升至94.49%。
註8:本公司透過益興生醫股份有限公司於民國111年4月以美金7,878,512元取得Second Source Medical LLC 100%股權，並自該日起新增併入合併個體，請詳附註六(二十六)說明。
註9:Panther Orthopedics, Inc.於民國111年12月經董事會決議後辦理解散清算。</ix:nonNumeric></pre></td>
					</tr> 
				</table> 
			<div style="text-align:center">未列入合併財務報表之子公司</div>
			<div style="text-align:center">無此情形／免揭露</div>
				<br />
				<table style="width:90%">
					<tr>
						<td>　 外幣</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:ForeignCurrencies" contextRef="From20220101To20221231" escape="true">

　　　　本集團內每一個體之財務報告所列之項目，均係以該個體營運所處主要經濟環境之貨幣
　　　　（即功能性貨幣）衡量。本合併財務報告係以本公司之功能性貨幣「新台幣」作為表達
　　　　貨幣列報。
　　　　1.外幣交易及餘額
　　　　　(1)外幣交易採用交易日或衡量日之即期匯率換算為功能性貨幣，換算此等交易產生之
　　　　　　　換算差額認列為當期損益。
　　　　　(2)外幣貨幣性資產及負債餘額，按資產負債表日之即期匯率評價調整，因調整而產生
　　　　　　　之換算差額認列為當期損益。
　　　　　(3)外幣非貨幣性資產及負債餘額，屬透過損益按公允價值衡量者，按資產負債表日之
　　　　　　　即期匯率評價調整，因調整而產生之兌換差額認列為當期損益；屬透過其他綜合損
　　　　　　　益按公允價值衡量者，按資產負債表日之即期匯率評價調整，因調整而產生之兌換
　　　　　　　差額認列於其他綜合損益項目；屬非按公允價值衡量者，則按初始交易日之歷史匯
　　　　　　　率衡量。
　　　　　(4)所有兌換損益於合併綜合損益表之「其他利益及損失」列報。
　　　　2.國外營運機構之換算
　　　　　(1)功能性貨幣與表達貨幣不同之所有集團個體，其經營結果和財務狀況以下列方式換
　　　　　　　算為表達貨幣：
　　　　　　　A.表達於每一資產負債表之資產及負債係以該資產負債表日之收盤匯率換算；
　　　　　　　B.表達於每一綜合損益表之收益及費損係以當期平均匯率換算；及
　　　　　　　C.所有因換算而產生之兌換差額認列為其他綜合損益。
　　　　　(2)當部分處分或出售之國外營運機構為子公司時，係按比例將認列為其他綜合損益之
　　　　　　　累計兌換差額重新歸屬予該國外營運機構之非控制權益。惟當本集團即使仍保留對
　　　　　　　前子公司之部分權益，但已喪失對國外營運機構屬子公司之控制，則係以處分對國
　　　　　　　外營運機構之全部權益處理。






</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　 資產與負債區分流動與非流動之標準</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:ClassificationOfCurrentAndNoncurrentAssetsAndLiabilities" contextRef="From20220101To20221231" escape="true">

　　　　1.資產符合下列條件之一者，分類為流動資產：
　　　　　(1)預期將於正常營業週期中實現該資產，或意圖將其出售或消耗者。
　　　　　(2)主要為交易目的而持有者。
　　　　　(3)預期於資產負債表日後十二個月內實現者。
　　　　　(4)現金或約當現金，但於資產負債表日後至少十二個月交換或用以清償負債受到限制
　　　　　　　者除外。
　　　　　本集團將所有不符合上述條件之資產分類為非流動。
　　　　2.負債符合下列條件之一者，分類為流動負債：
　　　　　(1)預期將於正常營業週期中清償者。
　　　　　(2)主要為交易目的而持有者。
　　　　　(3)預期於資產負債表日後十二個月內到期清償者。
　　　　　(4)不能無條件將清償期限遞延至資產負債表日後至少十二個月者。負債之條款，可能
　　　　　　　依交易對方之選擇，以發行權益工具而導致清償者，不影響其分類。
　　　　　本集團將所有不符合上述條件之負債分類為非流動。



</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　 現金及約當現金</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CashAndCashEquivalents" contextRef="From20220101To20221231" escape="true">

　　　　約當現金係指短期並具高度流動性之投資，該投資可隨時轉換成定額現金且價值變動之
　　　　風險甚小。定期存款符合前述定義且其持有目的係為滿足營運上之短期現金承諾者，分
　　　　類為約當現金。






</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　　　 透過損益按公允價值衡量之金融資產</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:FinancialAssetsAtFairValueThroughProfitOrLoss" contextRef="From20220101To20221231" escape="true">

　　　　1.係指非屬按攤銷後成本衡量或透過其他綜合損益按公允價值衡量之金融資產。
　　　　2.本集團對於符合慣例交易之透過損益按公允價值衡量之金融資產係採用交易日會計。
　　　　3.本集團於原始認列時按公允價值衡量，相關交易成本認列於損益，後續按公允價值衡
　　　　　量，其利益或損失認列於損益。
　　　　4.當收取股利之權利確立，與股利有關之經濟效益很有可能流入，及股利金額能可靠衡
　　　　　量時，本集團於損益認列股利收入。






</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　　　 按攤銷後成本衡量之金融資產</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:FinancialAssetsAtAmortisedCost" contextRef="From20220101To20221231" escape="true">

　　　　1.係指同時符合下列條件者：
　　　　　(1)在以收取合約現金流量為目的之經營模式下持有該金融資產。
　　　　　(2)該金融資產之合約條款產生特定日期之現金流量，完全為支付本金及流通在外本金
　　　　　　　金額之利息。
　　　　2.本集團對於符合交易慣例之按攤銷後成本衡量之金融資產係採用交易日會計。
　　　　3.本集團持有不符合約當現金之定期存款，因持有期間短，折現之影響不重大，係以投
　　　　　資金額衡量。






</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　　　 金融資產減損</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:ImpairmentOfFinancialAssets" contextRef="From20220101To20221231" escape="true">

　　　　本集團於每一資產負債表日，按攤銷後成本衡量之金融資產，考量所有合理且可佐證之
　　　　資訊(包括前瞻性者)後，對自原始認列後信用風險並未顯著增加者，按12個月預期信用
　　　　損失金額衡量備抵損失；對自原始認列後信用風險已顯著增加者，按存續期間預期信用
　　　　損失金額衡量備抵損失；就不包含重大財務組成部分之應收帳款或合約資產，按存續期
　　　　間預期信用損失金額衡量備抵損失。






</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　　　 金融資產之除列</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:DerecognitionOfFinancialAssets" contextRef="From20220101To20221231" escape="true">

　　　　　當本集團對收取來自金融資產現金流量之合約權利失效時，將除列金融資產。






</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　　　 金融負債之除列</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:DerecognitionOfFinancialLiabilities" contextRef="From20220101To20221231" escape="true">

　　　　　本集團於合約所載之義務履行、取消或到期時，除列金融負債。






</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　　　 金融資產及負債之互抵</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:OffsettingFinancialAssetsAndFinancialLiabilities" contextRef="From20220101To20221231" escape="true">

　　　　　　當有法律上可執行之權利將所認列之金融資產及負債金額抵銷，且意圖以淨額基礎交
　　　　　　割或同時實現資產及清償負債時，始可將金融資產及金融負債互抵，並於資產負債表
　　　　　　中以淨額表達。






</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　 存貨</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:Inventories" contextRef="From20220101To20221231" escape="true">

　　　　　存貨按成本與淨變現價值孰低者衡量，成本依加權平均法決定。製成品及在製品之成
　　　　　本包括原料、直接人工、其他直接成本及生產相關之製造費用（按正常產能分攤），
　　　　　惟不包括借款成本。比較成本與淨變現價值孰低時，採逐項比較法，淨變現價值係指
　　　　　在正常營業過程中之估計售價減除至完工尚須投入之估計成本及相關變動銷售費用後
　　　　　之餘額。






</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　 投資關聯企業</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:InvestmentsInAssociates" contextRef="From20220101To20221231" escape="true">

　　　　　1.關聯企業指所有本集團對其有重大影響而無控制之個體，一般係直接或間接持有其20
　　　　　　%以上表決權之股份。本集團對關聯企業之投資採用權益法處理，取得時依成本認列
　　　　　　。
　　　　　2.本集團對關聯企業取得後之損益份額認列為當期損益，對其取得後之其他綜合損益
　　　　　　份額則認列為其他綜合損益。如本集團對任一關聯企業之損失份額等於或超過其在該
　　　　　　關聯企業之權益（包括任何其他無擔保之應收款），本集團不認列進一步之損失，除
　　　　　　非本集團對該關聯企業發生法定義務、推定義務或已代其支付款項。
　　　　　3.當關聯企業發生非損益及其他綜合損益之權益變動且不影響對關聯企業之持股比例
　　　　　　時，本集團將歸屬於本集團可享有關聯企業份額下之權益變動按持股比例認列為「資
　　　　　　本公積」。
　　　　　4.本集團與關聯企業間交易所產生之未實現損益業已依其對關聯企業之權益比例銷除
　　　　　　；除非證據顯示該交易所轉讓之資產已減損，否則未實現損失亦予以銷除。關聯企業
　　　　　　之會計政策已作必要之調整，與本集團採用之政策一致。
　　　　　5.關聯企業增發新股時，若本集團未按比例認購或取得，致使投資比例發生變動但仍
　　　　　　對其有重大影響，該股權淨值變動之增減數係調整「資本公積」及「採用權益法之投
　　　　　　資」。若致使投資比例下降者，除上述調整外，與該所有權權益之減少有關而先前已
　　　　　　認列於其他綜合損益之利益或損失，且該利益或損失於處分相關資產或負債時須被重
　　　　　　分類至損益者，依減少比例重分類至損益。
　　　　　6.當集團喪失對關聯企業之重大影響，對原關聯企業之剩餘投資係按公允價值重新衡
　　　　　　量，公允價值與帳面金額之差額認列為當期損益。
　　　　　7.當集團處分關聯企業時，如喪失對該關聯企業之重大影響，對於先前認列於其他綜
　　　　　　合損益與該關聯企業有關之所有金額，其會計處理與本集團若直接處分相關資產或負
　　　　　　債之基礎相同，亦即如先前認列為其他綜合損益之利益或損失，於處分相關資產或負
　　　　　　債時將被重分類為損益，則當喪失對關聯企業之重大影響時，將該利益或損失自權益
　　　　　　重分類為損益。如仍對該關聯企業有重大影響，僅按比例將先前在其他綜合損益中認
　　　　　　列之金額依上述方式轉出。
　　　　　8.當集團處分關聯企業時，如喪失對該關聯企業之重大影響，將與該關聯企業有關之
　　　　　　資本公積轉列損益；如仍對該關聯企業有重大影響，則按處分比例轉列損益。






</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　 不動產（、廠房）及設備</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:PropertyPlantAndEquipment" contextRef="From20220101To20221231" escape="true">

　　　　　1.不動產、廠房及設備係以取得成本為入帳基礎，並將購建期間之有關利息資本化。
　　　　　2.後續成本只有在與該項目有關之未來經濟效益很有可能流入本集團，且該項目之成
　　　　　　本能可靠衡量時，才包括在資產之帳面金額或認列為一項單獨資產。被重置部分之帳
　　　　　　面金額應除列。所有其他維修費用於發生時認列為當期損益。
　　　　　3.不動產、廠房及設備之後續衡量採成本模式，按估計耐用年限以直線法計提折舊。
　　　　　　不動產、廠房及設備各項組成若屬重大，則單獨提列折舊。
　　　　　4.本集團於每一財務年度結束日對各項資產之殘值、耐用年限及折舊方法進行檢視，
　　　　　　若殘值及耐用年限之預期值與先前之估計不同時，或資產所含之未來經濟效益之預期
　　　　　　消耗型態已有重大變動，則自變動發生日起依國際會計準則第8號「會計政策、會計
　　　　　　估計變動及錯誤」之會計估計變動規定處理。
　　　　　　各項資產之耐用年限如下：
　　　　　　研發設備                           3年 
　　　　　　辦公設備                           3年 ∼ 5年
　　　　　　機器設備                           3年 ∼ 10年
　　　　　　租賃改良                           3年 ∼ 11年






</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　 無形資產</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:IntangibleAssets" contextRef="From20220101To20221231" escape="true">

　　　　　1.電腦軟體以取得成本認列，依直線法按估計耐用年限2∼5年攤銷。
　　　　　2.專利權採直線法攤銷，攤銷年限按經濟效益年限10年攤銷。
　　　　　3.顧客關係採直線法攤銷，攤銷年限按經濟效益年限8年攤銷。
　　　　　4.專有技術採直線法攤銷，攤銷年限按經濟效益年限15年攤銷。
　　　　　5.商譽係因企業合併採收購法而產生。






</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　 非金融資產減損</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:ImpairmentOfNonFinancialAsset" contextRef="From20220101To20221231" escape="true">

　　　　　1.本集團於資產負債表日針對有減損跡象之資產，估計其可回收金額，當可回收金額
　　　　　　低於其帳面價值時，則認列減損損失。可回收金額係指一項資產之公允價值減處分成
　　　　　　本或其使用價值，兩者較高者。除商譽外，當以前年度已認列資產減損之情況不存在
　　　　　　或減少時，則迴轉減損損失，惟迴轉減損損失而增加之資產帳面金額，不超過該資產
　　　　　　若未認列減損損失情況下減除折舊或攤銷後之帳面金額。
　　　　　2.商譽定期估計其可回收金額。當可回收金額低於其帳面價值時，則認列減損損失。
　　　　　　商譽減損之減損損失於以後年度不予迴轉。
　　　　　3.商譽為減損測試之目的，分攤至現金產生單位。此項分攤是依據營運部門辨認，將
　　　　　　商譽分攤至預期可從產生商譽之企業合併而受益之現金產生單位或現金產生單位群組
　　　　　　。






</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　 收入之認列</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:RevenueRecognition" contextRef="From20220101To20221231" escape="true">

            1.智慧財產權出售收入及委託研究收入
　　　　　　　本集團與客戶簽訂智慧財產權出售及委託服務合約，將本集團之智慧產權讓與客戶
　　　　　　　，及提供後續之委託研究服務，經本集團分析其智慧財產權之讓與及後續研究服務
　　　　　　　係屬可區分，故將各別辨認為單獨履約義務。交易價格以相對單獨售價為基礎分攤
　　　　　　　至合約中每一履約義務；當單獨售價不可直接觀察時，則以預期成本加計利潤法估
　　　　　　　計。合約中所包含之變動對價，若預期與變動對價相關的不確定性消除時，高度很
　　　　　　　有可能不會導致重大的收入迴轉，則將變動對價包括在交易價格之中。就各類型收
　　　　　　　入認列方式如下:
　　　　　　　(1)智慧財產權出售收入
　　　　　　　　　本集團與客戶簽訂合約，將本集團之智慧財產權出售予客戶，則於智慧財產權移
　　　　　　　　　轉之時點認列收入。
　　　　　　　(2)委託研究收入
　　　　　　　　　本集團提供委託研究相關服務，勞務收入於服務提供予客戶之財務報導期間內認
　　　　　　　　　列為收入，固定價格之收入係以資產負債表日止已實際提供之服務占全部應提供
　　　　　　　　　服務之比例認列，服務之完工比例以實際總成本佔估計總成本之比例為基礎認列
　　　　　　　　　。若本集團缺乏應用適當衡量完成程度方法所需之可靠資訊，但本集團預期可回
　　　　　　　　　收滿足履約義務之已發生成本，於該等情況下，本集團於可合理衡量履約義務結
　　　　　　　　　果前，僅在已發生成本之範圍內認列收入。客戶依照所協議之付款時間表支付合
　　　　　　　　　約價款，當本集團已提供之服務超過客戶應付款時認列為合約資產，若客戶應付
　　　　　　　　　款超過本集團已提供之服務時則認列為合約負債。
　　　　　　　　　本集團對收入、成本及完工程度之估計隨情況改變進行修正。任何導因於估計變
　　　　　　　　　動之估計收入、成本增加或減少，於導致修正之情況被管理階層所知悉之期間內
　　　　　　　　　反映於損益。
　　　　　　2.商品銷售
　　　　　　　(1)本集團製造並銷售醫療器材等，銷貨收入於產品之控制移轉予買方時認列，且本集
　　　　　　　　　團並無尚未履行之履約義務可能影響買方接受該產品時。當產品被運送至指定地點
　　　　　　　　　，且買方依據銷售合約接受產品，或有客觀證據證明所有接受標準皆已滿足時，商
　　　　　　　　　品交付方屬發生。因移轉所承諾之商品或服務予客戶與客戶付款間之時間間隔未有
　　　　　　　　　超過一年者，因此本集團並未調整交易價格以反映貨幣時間價值。
　　　　　　　(2)應收帳款於商品交付予客戶時認列，因自該時點起本集團對合約價款具無條件權
　　　　　　　　　利，僅須時間經過即可自客戶收取對價。



</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　 借款成本</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:BorrowingCost" contextRef="From20220101To20221231" escape="true">

　　　　　　係指向銀行借入之長期款項。本集團於原始認列時按其公允價值減除交易成本衡量，後
            續就減除交易成本後之價款與贖回價值之任何差額，採有效利息法按攤銷程序於流通期
            間內認列利息費用於損益。



</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　 員工福利</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:EmployeeBenefits" contextRef="From20220101To20221231" escape="true">

　　　　　　1.短期員工福利
　　　　　　　短期員工福利係以預期支付之非折現金額衡量，並於相關服務提供時認列為費用。
　　　　　　2.退休金
　　　　　　　確定提撥計畫
　　　　　　　對於確定提撥計畫，係依權責發生基礎將應提撥之退休基金數額認列為當期之退休
　　　　　　　金成本。預付提撥金於可退還現金或減少未來給付之範圍內認列為資產。
　　　　　　3.員工酬勞及董監酬勞
　　　　　　　員工酬勞及董監事酬勞係於具法律或推定義務且金額可合理估計時，認列為費用及
　　　　　　　負債。嗣後決議實際配發金額與估列金額有差異時，則按會計估計變動處理。另以
　　　　　　　股票發放員工酬勞者，計算股數之基礎為董事會決議日前一日收盤價。






</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　 股份基礎給付</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:ShareBasedPayment" contextRef="From20220101To20221231" escape="true">

　　　　　　以權益交割之股份基礎給付協議係於給與日以所給與權益商品之公允價值衡量所取得
　　　　　　之員工勞務，於既得期間認列為酬勞成本，並相對調整權益。權益商品之公允價值應
　　　　　　反映市價既得條件及非既得條件之影響。認列之酬勞成本係隨著預期將符合服務條件
　　　　　　及非市價既得條件之獎酬數量予以調整，直至最終認列金額係以既得日既得數量認列
　　　　　　。






</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　 所得稅</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:IncomeTax" contextRef="From20220101To20221231" escape="true">

　　　　　　1.所得稅費用包含當期及遞延所得稅。除與列入其他綜合損益或直接列入權益之項目
　　　　　　　有關之所得稅分別列入其他綜合損益或直接列入權益外，所得稅係認列於損益。
　　　　　　2.本集團依據營運及產生應課稅所得之所在國家在資產負債表日已立法或已實質性立
　　　　　　　法之稅率計算當期所得稅。管理階層就適用所得稅相關法規定期評估所得稅申報之
　　　　　　　狀況，並在適用情況下根據預期須向稅捐機關支付之稅款估列所得稅負債。未分配
　　　　　　　盈餘依所得稅法加徵之所得稅，嗣盈餘產生年度之次年度於股東會通過盈餘分派案
　　　　　　　後，始就實際盈餘之分派情形，認列之未分配盈餘所得稅費用。
　　　　　　3.遞延所得稅採用資產負債表法，按資產及負債之課稅基礎與其於合併資產負債表之
　　　　　　　帳面金額所產生之暫時性差異認列。源自於原始認列之商譽所產生之遞延所得稅負
　　　　　　　債則不予認列，若遞延所得稅源自於交易（不包括企業合併）中對資產或負債之原
　　　　　　　始認列，且在交易當時未影響會計利潤或課稅所得(課稅損失)，則不予認列。若投
　　　　　　　資子公司產生之暫時性差異，本集團可以控制暫時性差異迴轉之時點，且暫時性差
　　　　　　　異很有可能於可預見之未來不會迴轉者則不予認列。遞延所得稅採用在資產負債表
　　　　　　　日已立法或已實質性立法，並於有關之遞延所得稅資產實現或遞延所得稅負債清償
　　　　　　　時預期適用之稅率（及稅法）為準。
　　　　　　4.遞延所得稅資產於暫時性差異很有可能用以抵減未來應課稅所得之範圍內認列，並
　　　　　　　於每一資產負債表日重評估未認列及已認列之遞延所得稅資產。
　　　　　　5.當有法定執行權將所認列之當期所得稅資產及負債金額互抵且有意圖以淨額基礎清
　　　　　　　償或同時實現資產及清償負債時，始將當期所得稅資產及當期所得稅負債互抵；當
　　　　　　　有法定執行權將當期所得稅資產及當期所得稅負債互抵，且遞延所得稅資產及負債
　　　　　　　由同一稅捐機關課徵所得稅之同一納稅主體、或不同納稅主體產生但各主體意圖以
　　　　　　　淨額基礎清償或同時實現資產及清償負債時，始將遞延所得稅資產及負債互抵。
　　　　　　6.因研究發展支出產生之未使用所得稅抵減遞轉後期部分，係在很有可能未來課稅所
　　　　　　　得以供未使用所得稅抵減使用之範圍內，認列遞延所得稅資產。






</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　 企業合併</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:BusinessCombination" contextRef="From20220101To20221231" escape="true">

　　　　　　1.本集團採用收購法進行企業合併。合併對價根據所移轉之資產、所產生或承擔之負
　　　　　　　債及所發行之權益工具之公允價值計算，所移轉之對價包括或有對價約定所產生之
　　　　　　　任何資產和負債之公允價值。與收購有關之成本於發生時認列為費用。企業合併中
　　　　　　　所取得可辨認之資產及所承擔之負債，按收購日之公允價值衡量。本集團以個別收
　　　　　　　購交易為基準，非控制權益之組成部分屬現時所有權權益且其持有者有權於清算發
　　　　　　　生時按比例份額享有企業淨資產者，選擇按收購日公允價值或按非控制權益占被收
　　　　　　　購者可辨認淨資產之比例衡量；非控制權益之所有其他組成部分則按收購日公允價
　　　　　　　值衡量。
　　　　　　2.移轉對價、被收購者非控制權益，及先前已持有被收購者之權益之公允價值總額，
　　　　　　　若超過所取得可辨認資產及承擔之負債之公允價值，於收購日認列為商譽；所取得
　　　　　　　可辨認資產及承擔之負債之公允價值，若超過移轉對價、被收購者非控制權益，及
　　　　　　　先前已持有被收購者之權益之公允價值總額，該差額於收購日認列為當期損益。






</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td colspan="2">　 其他</td>
					</tr>
					<tr>
						<td style="text-align:center">項目</td>
						<td style="text-align:center">說明</td>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:Others">
						<td><pre class="note"><ix:nonNumeric name="tifrs-notes:Item" contextRef="From20220101To20221231" escape="true">應付帳款及票據</ix:nonNumeric></pre></td>
						<td><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20220101To20221231" escape="true">　　　　　1.係指因賒購原物料、商品或勞務所發生之債務及因營業與非因營業而發生之應付票
　　　　　　據。
　　　　　2.屬未付息之短期應付帳款及票據，因折現之影響不大，本集團係以原始發票金額衡
　　　　　　量。</ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:Others">
						<td><pre class="note"><ix:nonNumeric name="tifrs-notes:Item" contextRef="From20220101To20221231" escape="true">營運部門</ix:nonNumeric></pre></td>
						<td><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20220101To20221231" escape="true">　　　　　　本集團營運部門資訊與提供給主要營運決策者之內部管理報告採一致之方式報導。主
　　　　　　要營運決策者負責分配資源予營運部門並評估其績效，經辨識本集團之主要營運決策
　　　　　　者為董事會。</ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:Others">
						<td><pre class="note"><ix:nonNumeric name="tifrs-notes:Item" contextRef="From20220101To20221231" escape="true">應收帳款及票據</ix:nonNumeric></pre></td>
						<td><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20220101To20221231" escape="true">　　　　1.係指依合約約定，已具無條件收取因移轉商品或勞務所換得對價金額權利之帳款及票
　　　　　據。
　　　　2.屬未付息之短期應收帳款及票據，因折現之影響不大，本集團係以原始發票金額衡量
　　　　　。</ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:Others">
						<td><pre class="note"><ix:nonNumeric name="tifrs-notes:Item" contextRef="From20220101To20221231" escape="true">股本</ix:nonNumeric></pre></td>
						<td><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20220101To20221231" escape="true">　　　　　1.普通股分類為權益。直接歸屬於發行新股或認股權之增額成本以扣除所得稅後之淨額
　　　　　　於權益中列為價款減項。
　　　　　2.本公司買回已發行股票時，將所支付之對價包括任何可直接歸屬之增額成本以稅後淨
　　　　　　額認列為股東權益之減項。買回之股票後續再發行時，所收取之對價扣除任何可直接歸
　　　　　　屬之增額成本及所得稅影響後與帳面價值之差額認列為股東權益之調整。</ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:Others">
						<td><pre class="note"><ix:nonNumeric name="tifrs-notes:Item" contextRef="From20220101To20221231" escape="true">承租人之租賃交易－使用權資產/租賃負債</ix:nonNumeric></pre></td>
						<td><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20220101To20221231" escape="true">　　　　1.租賃資產於可供本集團使用之日認列為使用權資產及租賃負債。當租賃合約係屬短期租賃
          或低價值標的資產之租賃時，將租賃給付採直線法於租賃期間認列為費用。
　　　　2.租賃負債於租賃開始日將尚未支付之租賃給付按本集團增額借款利率折現後之現值認列，
          租賃給付包括固定給付，減除可收取之任何租賃誘因。
        後續採利息法按攤銷後成本法衡量，於租賃期間提列利息費用。當非屬合約修改造成租賃期
        間或租賃給付變動時，將重評估租賃負債，並將再衡量數調整使用權資產。
　　　　3.使用權資產於租賃開始日按成本認列，成本包括：
　　　　  (1)租賃負債之原始衡量金額；
　　　　  (2)於開始日或之前支付之任何租賃給付；
        後續採成本模式衡量，於使用權資產之耐用年限屆滿時或租賃期間屆滿時兩者之較早者，提
        列折舊費用。當租賃負債重評估時，使用權資產將調整租賃負債之任何再衡量數。
　　　　4.對減少租賃範圍之租賃修改，承租人將減少使用權資產之帳面金額以反映租賃部分或全面
          之終止，並將其與租賃負債再衡量金額間之差額認列於損益中。</ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr>
				</table>
			</div>
			<br />
			<div id="SourcesOfUncertaintyFromSignificantAccountingJudgmentsAssumptionsAndEstimations">
				<table style="width:90%">
					<tr>
						<th colspan='5' style="text-align:left">重大會計判斷、假設及估計不確性之主要來源</th>
					</tr> 
					<tr>
						<td>　 重大會計判斷、假設及估計不確性之主要來源</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:SourcesOfUncertaintyFromSignificantAccountingJudgmentsAssumptionsAndEstimations" contextRef="From20220101To20221231" escape="true">

　　本集團編製本合併財務報告時，管理階層已運用其判斷以決定所採用之會計政策，並依據
　　資產負債表日當時之情況對於未來事件之合理預期以作出會計估計及假設。所作出之重大
　　會計估計與假設可能與實際結果存有差異，將考量歷史經驗及其他因子持續評估及調整。
　　請詳下列對重大會計判斷、估計與假設不確定性之說明：
　　(一)會計政策採用之重要判斷
　　　　無此情形。
　　(二)重要會計估計及假設
　　　　1.商譽減損評估
　　　　　商譽減損之評估過程依賴本集團之主觀判斷，包含辨認現金產生單位及分攤資產負債
　　　　　和商譽至相關現金產生單位，及決定相關現金產生單位之可回收金額。
　　　　2.採用權益法之投資減損評估
　　　　　當有減損跡象顯示某項採權益法之投資可能已經減損致帳面金額無法被回收，本集團
　　　　　隨即評估該項投資之減損。本集團係依據享有被投資公司預期未來現金流量之折現值
　　　　　評估可回收金額，並分析其相關假設之合理性。






</ix:nonNumeric></pre></td>
					</tr>
				</table>
			</div>

			<br />
			<div id="TradeAndOtherReceivables"></div>
			<div class="title">應收款項</div>
			<div class="rptidx">單位：新臺幣仟元</div>
				<table style="width:90%">
					<tr>
						<th colspan='6' rowspan='1' style="text-align:left">明細表</th>
					</tr>
					<tr>
						<th colspan='6' rowspan='1' style="text-align:center">項目及金額</th>
					</tr>
					<tr>
						<th colspan='1' rowspan='2' style="text-align:center">項目</th>
						<th colspan='2' rowspan='1' style="text-align:center">金額</th>
					</tr>
					<tr>
						<th colspan='1' rowspan='1' style="text-align:center">本期</th>
						<th colspan='1' rowspan='1' style="text-align:center">去年同期</th>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:FinancialStatementAccountAndAmount">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount2" contextRef="AsOf20221231" escape="true">應收帳款</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount2" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">32,354</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount2" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">10,124</ix:nonFraction> </pre></td>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:FinancialStatementAccountAndAmount">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount2" contextRef="AsOf20221231" escape="true">減：備抵損失</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount2" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount2" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						</ix:tuple>
					</tr>
					<tr>
						<th style="text-align:left" colspan='1'>合計</th>
						<td colspan='1' style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:TotalTradeAndOtherReceivables" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">32,354</ix:nonFraction> </pre></td>
						<td colspan='3' style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:TotalTradeAndOtherReceivables" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">10,124</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<th style="text-align:left" colspan='1'>說明</th>
						<td colspan='4' style="text-align:left"></td>
					</tr>
				</table>
				<br />
				<table style="width:90%">
					<tr>
						<th colspan='6' rowspan='1' style="text-align:left">應收款項之帳齡分析</th>
					</tr>
					<tr>
						<th colspan='6' rowspan='1' style="text-align:center">帳齡區間及金額</th>
					</tr>
					<tr>
						<th colspan='1' rowspan='2' style="text-align:center">帳齡區間</th>
						<th colspan='2' rowspan='1' style="text-align:center">金額</th>
					</tr>
					<tr>
						<th colspan='1' rowspan='1' style="text-align:center">本期</th>
						<th colspan='1' rowspan='1' style="text-align:center">去年同期</th>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:AgeDistributionAndAmount">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:AgeDistribution" contextRef="AsOf20221231" escape="true">未逾期</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount2" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">20,872</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount2" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,581</ix:nonFraction> </pre></td>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:AgeDistributionAndAmount">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:AgeDistribution" contextRef="AsOf20221231" escape="true">30天內</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount2" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,980</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount2" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,511</ix:nonFraction> </pre></td>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:AgeDistributionAndAmount">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:AgeDistribution" contextRef="AsOf20221231" escape="true">31-90天</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount2" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,438</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount2" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,032</ix:nonFraction> </pre></td>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:AgeDistributionAndAmount">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:AgeDistribution" contextRef="AsOf20221231" escape="true">91-180天</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount2" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,064</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount2" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						</ix:tuple>
					</tr>
					<tr>
						<th style="text-align:left" colspan='1'>合計</th>
						<td colspan='1' style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:TotalPastDueButNotImpaired" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">32,354</ix:nonFraction> </pre></td>
						<td colspan='3' style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:TotalPastDueButNotImpaired" contextRef="AsOf20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">10,124</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<th style="text-align:left" colspan='1'>說明</th>
						<td colspan='4' style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:AgingAnalysisOfReceivablesThatArePastDueButNotImpaired2" contextRef="AsOf20221231" escape="true">以上係以逾期天數為基準進行之帳齡分析。</ix:nonNumeric></pre></td>
					</tr>
				</table>
				<br /> 
				<table style="width:90%"> 
					<tr> 
						<th colspan='3' style="text-align:left">應收款項之備抵損失變動資訊</th> 
					</tr> 
					<tr> 
						<th></th> 
						<th colspan='1'>本期</th> 
						<th colspan='1'>去年同期</th> 
					</tr>
					<tr> 
						<th style="text-align:center"></th> 
						<th style="text-align:center">金額</th>
						<th style="text-align:center">金額</th>
					</tr> 
					<tr>
						<th style="text-align:left">　期初餘額</th>
					　<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance2" contextRef="AsOf20221231_Total3" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance2" contextRef="AsOf20211231_Total3" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">506</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<th style="text-align:left">　追溯適用IFRS 9影響數</th>
					　<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EffectOfRetrospectiveApplicationOfIFRS9" contextRef="From20220101To20221231_Total3" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EffectOfRetrospectiveApplicationOfIFRS9" contextRef="From20210101To20211231_Total3" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<th style="text-align:left">　提列減損損失</th>
					　<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ProvisionForImpairmentLoss" contextRef="From20220101To20221231_Total3" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ProvisionForImpairmentLoss" contextRef="From20210101To20211231_Total3" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<th style="text-align:left">　減損損失迴轉</th>
					　<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ReversalOfImpairmentLoss" contextRef="From20220101To20221231_Total3" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ReversalOfImpairmentLoss" contextRef="From20210101To20211231_Total3" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<th style="text-align:left">　因無法收回而沖銷之款項</th>
					　<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:WriteOffsChargedAgainstTheAllowanceAccounts" contextRef="From20220101To20221231_Total3" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:WriteOffsChargedAgainstTheAllowanceAccounts" contextRef="From20210101To20211231_Total3" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<th style="text-align:left">　折現轉回數</th>
					　<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ReversalOfDiscount" contextRef="From20220101To20221231_Total3" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ReversalOfDiscount" contextRef="From20210101To20211231_Total3" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<th style="text-align:left">　匯率影響數</th>
					　<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:CurrencyTranslationDifferences" contextRef="From20220101To20221231_Total3" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:CurrencyTranslationDifferences" contextRef="From20210101To20211231_Total3" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<th style="text-align:left">　其他</th>
					　<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Others1" contextRef="From20220101To20221231_Total3" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:Others1" contextRef="From20210101To20211231_Total3" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">506</ix:nonFraction>)</pre></td>
					</tr>
					<tr>
						<th style="text-align:left">　期末餘額</th>
					　<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance4" contextRef="AsOf20221231_Total3" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance4" contextRef="AsOf20211231_Total3" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<th style="text-align:left">說明</th>
						<td  colspan='2' style="text-align:left"></td>
					</tr>
				</table>
			<br />
			<div id="TransactionsBetweenRelatedParties"></div>
			<div class="title">關係人交易</div>
			<div class="rptidx">單位：新臺幣仟元</div>
			<br />
			<div style="text-align:center"> 母公司及最終控制者之名稱</div>
			<div style="text-align:center">無此情形／免揭露</div>
				<br />
				<table style="width:90%">
					<tr>
						<th colspan='2' rowspan='1' style="text-align:left">關係人名稱及關係</th>
					</tr>
					<tr>
						<th colspan='1' rowspan='1' style="text-align:center">關係人名稱</th>
						<th colspan='1' rowspan='1' style="text-align:center">關係人關係</th>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NameAndRelatiohshipOfRelatedParty2">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:NameOfRelatedParty" contextRef="AsOf20221231" escape="true">達亞國際股份有限公司(達亞)</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelatedPartyRelationship" contextRef="AsOf20221231" escape="true">本集團對該個體具重大影響</ix:nonNumeric></pre></td> 
						</ix:tuple>
					</tr>
					<tr>
					<th style="text-align:left" colspan='1'>說明</th> 
						<td colspan='3' style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameAndRelatiohshipOfRelatedParty" contextRef="From20220101To20221231" escape="true">註:本集團於民國110年6月處分達亞國際股份有限公司部份股權後，經評估已不具控制力，僅具重大影響。</ix:nonNumeric></pre></td> 
					</tr>
				</table>
			<br />
			<div class="title">與關係人間之重大交易事項</div>
			<div class="rptidx">單位：新臺幣仟元</div>
			<div style="text-align:center">營業收入</div>
			<div style="text-align:center">無此情形／免揭露</div>
			<div style="text-align:center">進貨</div>
			<div style="text-align:center">無此情形／免揭露</div>
			<div style="text-align:center">應收關係人款項</div>
			<div style="text-align:center">無此情形／免揭露</div>
			<div style="text-align:center">應付關係人款項</div>
			<div style="text-align:center">無此情形／免揭露</div>
			<div style="text-align:center">預付款項</div>
			<div style="text-align:center">無此情形／免揭露</div>
			<div style="text-align:center">取得不動產、廠房及設備</div>
			<div style="text-align:center">無此情形／免揭露</div>
			<div style="text-align:center">處分不動產、廠房及設備</div>
			<div style="text-align:center">無此情形／免揭露</div>
			<div style="text-align:center">取得投資性不動產</div>
			<div style="text-align:center">無此情形／免揭露</div>
			<div style="text-align:center">處分投資性不動產</div>
			<div style="text-align:center">無此情形／免揭露</div>
			<div style="text-align:center">取得金融資產</div>
			<div style="text-align:center">無此情形／免揭露</div>
			<div style="text-align:center">處分金融資產</div>
			<div style="text-align:center">無此情形／免揭露</div>
			<div style="text-align:center">取得其他資產</div>
			<div style="text-align:center">無此情形／免揭露</div>
			<div style="text-align:center">處分其他資產</div>
			<div style="text-align:center">無此情形／免揭露</div>
			<div style="text-align:center">對關係人放款</div>
			<div style="text-align:center">無此情形／免揭露</div>
			<div style="text-align:center"> 背書保證</div>
			<div style="text-align:center">無此情形／免揭露</div>
				<br />
				<table style="width:90%">
					<tr>
						<td style="width:120px"> 其它</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:OtherTransactionWithRelatedParties" contextRef="From20220101To20221231" escape="true">


　　　　1.營業成本
                                111年度                 110年度          
                        ----------------------  ---------------------- 
              達亞       $              4,615    $                433   
                        ======================  ======================  
　　　　　係本集團委託達亞國際協助進行醫療器材開發製造，交易條件依雙方議定方式辦理，付款期間約為30~60天。

　　　　2.營業費用
                                111年度                 110年度            
                        ----------------------  ----------------------  
              達亞       $                156    $              2,050   
                        ======================  ======================   
　　　　　係本集團委託達亞國際協助進行醫療器材產品研究發展計劃，交易條件依雙方議定方式辦理，付款期間為30~60天。
　　　　
        3.其他收入
                                111年度                 110年度         
                        ----------------------  ----------------------   
              達亞       $                  -    $                 26  
                        ======================  ======================  
　　　　　本集團與達亞國際之交易係出售研發材料，收款期間為30~60天。
　　　
      　4.其他應收款
                             111年12月31日          110年12月31日      
                        ----------------------  ----------------------   
              達亞       $                  -    $                 27  
                        ======================  ======================  



</ix:nonNumeric></pre></td>
					</tr>
				</table>
			<div style="text-align:center">向關係人借款</div>
			<div style="text-align:center">無此情形／免揭露</div>
				<br />
				<table style="width:90%">
					<tr> 
						<th colspan='3' style="text-align:left">主要管理階層薪酬</th> 
					</tr> 
					<tr> 
						<th></th> 
						<th colspan='1'>本年度</th>
						<th colspan='1'>上年度</th>
					</tr>
					<tr>
						<th style="text-align:left">短期員工福利</th>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ShortTermEmployeeBenefits" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">93,716</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ShortTermEmployeeBenefits" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">89,978</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<th style="text-align:left">退職後福利</th>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PostEmploymentBenefits" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PostEmploymentBenefits" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<th style="text-align:left">其他長期員工福利</th>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:OtherLongTermBenefits" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:OtherLongTermBenefits" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<th style="text-align:left">離職福利</th>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:TerminationBenefits" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:TerminationBenefits" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<th style="text-align:left">股份基礎給付</th>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ShareBasedPayment2" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">86</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ShareBasedPayment2" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,310</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<th style="text-align:left">合計</th>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:TotalKeyManagementPersonnelCompensation" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">93,802</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:TotalKeyManagementPersonnelCompensation" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">94,288</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<th style="text-align:left">說明</th>
						<td  colspan='3' style="text-align:left"></td>
					</tr>
				</table>
			<br />
			<div id="LoansToOthers"></div>
			<div style="text-align:center">資金貸與他人</div>
			<div style="text-align:center">無此情形／免揭露</div>
			<br />
			<div id="EndorsementGuaranteeProvidedToOthers"></div>
			<div style="text-align:center">為他人背書保證</div>
			<div style="text-align:center">無此情形／免揭露</div>
			<br />
			<div id="SignificantIntercompanyTransactionsBetweenConsolidatedEntities"></div>
			<div class="title">母子公司間業務關係及重要交易往來情形</div>
			<div class="rptidx">單位：新臺幣仟元</div>
				<table style="width:90%">
					<tr>
						<th colspan='8' rowspan='1' style="text-align:left">母子公司間業務關係及重要交易往來情形</th>
					</tr>
					<tr>
						<th colspan='1' rowspan='2' style="text-align:center">編號</th>
						<th colspan='1' rowspan='2' style="text-align:center">交易人名稱</th>
						<th colspan='1' rowspan='2' style="text-align:center">交易往來對象</th>
						<th colspan='1' rowspan='2' style="text-align:center">與交易人之關係</th>
						<th colspan='4' rowspan='1' style="text-align:center">交易往來情形</th>
					</tr>
					<tr>
						<th colspan='1' rowspan='1' style="text-align:center">科目</th>
						<th colspan='1' rowspan='1' style="text-align:center">金額</th>
						<th colspan='1' rowspan='1' style="text-align:center">交易條件</th>
						<th colspan='1' rowspan='1' style="text-align:center">佔合併總營收或總資產之比率</th>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20220101To20221231" escape="true">益安生醫股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20220101To20221231" escape="true">Medeon International, Inc.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20220101To20221231" escape="true">1</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20220101To20221231" escape="true">其他應付款-關係人</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">6,854</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20220101To20221231" escape="true">由雙方議定</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.17</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20220101To20221231" escape="true">益安生醫股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20220101To20221231" escape="true">意能生技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20220101To20221231" escape="true">1</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20220101To20221231" escape="true">其他收入</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">13,678</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20220101To20221231" escape="true">由雙方議定</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">4.59</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20220101To20221231" escape="true">益安生醫股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20220101To20221231" escape="true">意能生技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20220101To20221231" escape="true">1</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20220101To20221231" escape="true">其他應收款-關係人</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,931</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20220101To20221231" escape="true">由雙方議定</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.07</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20220101To20221231" escape="true">益安生醫股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20220101To20221231" escape="true">益興生醫股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20220101To20221231" escape="true">1</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20220101To20221231" escape="true">其他收入</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,500</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20220101To20221231" escape="true">由雙方議定</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">1.51</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20220101To20221231" escape="true">益安生醫股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20220101To20221231" escape="true">益興生醫股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20220101To20221231" escape="true">1</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20220101To20221231" escape="true">其他應收款-關係人</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,725</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20220101To20221231" escape="true">由雙方議定</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.12</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20220101To20221231" escape="true">益安生醫股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20220101To20221231" escape="true">Aquedeon Medical, Inc.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20220101To20221231" escape="true">1</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20220101To20221231" escape="true">其他收入</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,224</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20220101To20221231" escape="true">由雙方議定</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.41</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20220101To20221231" escape="true">益安生醫股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20220101To20221231" escape="true">MedeonBio, Inc.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20220101To20221231" escape="true">1</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20220101To20221231" escape="true">其他應付款-關係人</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">18,426</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20220101To20221231" escape="true">由雙方議定</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.46</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20220101To20221231" escape="true">益安生醫股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20220101To20221231" escape="true">MedeonBio, Inc.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20220101To20221231" escape="true">1</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20220101To20221231" escape="true">營業費用</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">18,426</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20220101To20221231" escape="true">由雙方議定</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">6.18</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20220101To20221231" escape="true">1</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20220101To20221231" escape="true">MedeonBio, Inc.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20220101To20221231" escape="true">意能生技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20220101To20221231" escape="true">3</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20220101To20221231" escape="true">其他收入</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">14,683</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20220101To20221231" escape="true">由雙方議定</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">4.92</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20220101To20221231" escape="true">1</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20220101To20221231" escape="true">MedeonBio, Inc.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20220101To20221231" escape="true">Aquedeon Medical, Inc.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20220101To20221231" escape="true">3</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20220101To20221231" escape="true">其他收入</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">29,240</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20220101To20221231" escape="true">由雙方議定</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">9.80</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20220101To20221231" escape="true">1</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20220101To20221231" escape="true">MedeonBio, Inc.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20220101To20221231" escape="true">Aquedeon Medical, Inc.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20220101To20221231" escape="true">3</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20220101To20221231" escape="true">應收帳款-關係人</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,709</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20220101To20221231" escape="true">由雙方議定</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.07</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20220101To20221231" escape="true">1</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20220101To20221231" escape="true">MedeonBio, Inc.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20220101To20221231" escape="true">Prodeon Medical, Inc.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20220101To20221231" escape="true">3</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20220101To20221231" escape="true">其他收入</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">19,498</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20220101To20221231" escape="true">由雙方議定</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">6.54</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20220101To20221231" escape="true">1</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20220101To20221231" escape="true">MedeonBio, Inc.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20220101To20221231" escape="true">Prodeon Medical, Inc.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20220101To20221231" escape="true">3</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20220101To20221231" escape="true">營業費用</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">360</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20220101To20221231" escape="true">由雙方議定</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.12</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20220101To20221231" escape="true">1</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20220101To20221231" escape="true">MedeonBio, Inc.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20220101To20221231" escape="true">Second Source Medical LLC</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20220101To20221231" escape="true">3</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20220101To20221231" escape="true">應收帳款-關係人</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,068</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20220101To20221231" escape="true">由雙方議定</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.05</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20220101To20221231" escape="true">1</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20220101To20221231" escape="true">MedeonBio, Inc.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20220101To20221231" escape="true">Second Source Medical LLC</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20220101To20221231" escape="true">3</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20220101To20221231" escape="true">其他收入</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">8,985</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20220101To20221231" escape="true">由雙方議定</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">3.01</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20220101To20221231" escape="true">1</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20220101To20221231" escape="true">MedeonBio, Inc.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20220101To20221231" escape="true">Second Source Medical LLC</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20220101To20221231" escape="true">3</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20220101To20221231" escape="true">營業成本</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">170</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20220101To20221231" escape="true">由雙方議定</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.06</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20220101To20221231" escape="true">1</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20220101To20221231" escape="true">MedeonBio, Inc.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20220101To20221231" escape="true">Second Source Medical LLC</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20220101To20221231" escape="true">3</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20220101To20221231" escape="true">營業費用</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">349</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20220101To20221231" escape="true">由雙方議定</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.12</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20220101To20221231" escape="true">3</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20220101To20221231" escape="true">意能生技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20220101To20221231" escape="true">Prodeon Medical, Inc.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20220101To20221231" escape="true">3</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20220101To20221231" escape="true">營業費用</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">207,016</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20220101To20221231" escape="true">由雙方議定</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">69.39</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20220101To20221231" escape="true">3</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20220101To20221231" escape="true">意能生技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20220101To20221231" escape="true">Prodeon Medical, Inc.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20220101To20221231" escape="true">3</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20220101To20221231" escape="true">其他應付款-關係人</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">52,295</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20220101To20221231" escape="true">由雙方議定</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">1.29</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20220101To20221231" escape="true">6</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20220101To20221231" escape="true">Second Source Medical LLC</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20220101To20221231" escape="true">MediBalloon, Inc.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20220101To20221231" escape="true">3</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20220101To20221231" escape="true">應收帳款-關係人</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">126</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20220101To20221231" escape="true">由雙方議定</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.00</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20220101To20221231" escape="true">6</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20220101To20221231" escape="true">Second Source Medical LLC</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20220101To20221231" escape="true">MediBalloon, Inc.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20220101To20221231" escape="true">3</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20220101To20221231" escape="true">其他收入</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">399</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20220101To20221231" escape="true">由雙方議定</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.13</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
					<th style="text-align:left" colspan='1'>備註</th> 
						<td colspan='11' style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:Note-SignificantIntercompanyTransactionsBetweenConsolidatedEntities" contextRef="From20220101To20221231" escape="true">註1：上述母公司與子公司及子公司間之交易，於編製合併財務報告時皆已沖銷，另相對之關係人交易不另行揭露。
註2：母公司及子公司相互間之業務往來資訊應分別於編號欄註明，編號之填寫方法如下：
     益安生醫股份有限公司 : 0
     MedeonBio,Inc.：1
     Medeon International,Inc.：2 
     意能生技股份有限公司：3
     Aquedeon Medical, Inc.：4
     Prodeon Medical, Inc.：5
     Second Source Medical LLC：6
     MediBalloon, Inc.：7
註3：與交易人之關係有以下三種，標示種類即可：
     1.母公司對子公司。
     2.子公司對母公司。
     3.子公司對子公司。</ix:nonNumeric></pre></td> 
					</tr>
				</table>
			<br />
			<div id="NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence"></div>
			<div class="title">被投資公司名稱、所在地區…等相關資訊</div>
			<div class="rptidx">單位：新臺幣仟元；股數：股</div>
				<table style="width:90%">
					<tr>
						<th colspan='13' rowspan='1' style="text-align:left">被投資公司名稱、所在地區…等相關資訊</th>
					</tr>
					<tr>
						<th colspan='1' rowspan='2' style="text-align:center">投資公司名稱</th>
						<th colspan='1' rowspan='2' style="text-align:center">被投資公司名稱</th>
						<th colspan='1' rowspan='2' style="text-align:center">地區別代號</th>
						<th colspan='1' rowspan='2' style="text-align:center">所在地區</th>
						<th colspan='1' rowspan='2' style="text-align:center">主要營業項目</th>
						<th colspan='2' rowspan='1' style="text-align:center">原始投資金額</th>
						<th colspan='3' rowspan='1' style="text-align:center">期末持股情形</th>
						<th colspan='1' rowspan='2' style="text-align:center">被投資公司本期損益</th>
						<th colspan='1' rowspan='2' style="text-align:center">本期認列之投資損益</th>
						<th colspan='1' rowspan='2' style="text-align:center">備註</th>
					</tr>
					<tr>
						<th colspan='1' rowspan='1' style="text-align:center">本期期末</th>
						<th colspan='1' rowspan='1' style="text-align:center">去年年底</th>
						<th colspan='1' rowspan='1' style="text-align:center">股數</th>
						<th colspan='1' rowspan='1' style="text-align:center">比率</th>
						<th colspan='1' rowspan='1' style="text-align:center">帳面金額</th>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">益安生醫股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20220101To20221231" escape="true">達亞國際股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20220101To20221231" escape="true">台灣</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20220101To20221231" escape="true">醫療零件製造及銷售</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">149,726</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">149,726</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20221231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">7,206,777</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">27.84</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,876,293</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">171,298</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">47,689</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Note" contextRef="From20220101To20221231" escape="true">-</ix:nonNumeric></pre></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">益安生醫股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20220101To20221231" escape="true">意能生技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20220101To20221231" escape="true">台灣</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20220101To20221231" escape="true">醫療器材製造及研發</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">967,658</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">572,858</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20221231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">16,848,500</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">85.05</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">167,514</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">283,455</ix:nonFraction>)</pre></td> 
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">237,854</ix:nonFraction>)</pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Note" contextRef="From20220101To20221231" escape="true">註4</ix:nonNumeric></pre></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">益安生醫股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20220101To20221231" escape="true">益創生醫股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20220101To20221231" escape="true">台灣</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20220101To20221231" escape="true">醫療器材銷售</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">100</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">100</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20221231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">10,000</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">74</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Note" contextRef="From20220101To20221231" escape="true">-</ix:nonNumeric></pre></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">益安生醫股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20220101To20221231" escape="true">益興生醫股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20220101To20221231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20220101To20221231" escape="true">台灣</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20220101To20221231" escape="true">醫療器材製造及銷售</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">600,000</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">140,000</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20221231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">30,614,174</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">94.49</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">445,680</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">152,603</ix:nonFraction>)</pre></td> 
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">144,779</ix:nonFraction>)</pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Note" contextRef="From20220101To20221231" escape="true">-</ix:nonNumeric></pre></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">益安生醫股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20220101To20221231" escape="true">MedeonBio, Inc.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20220101To20221231" escape="true">211</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20220101To20221231" escape="true">美國</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20220101To20221231" escape="true">醫療器材製造及研發</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">159,912</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20221231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">2,900,000</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.00</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">25,079</ix:nonFraction>)</pre></td> 
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">25,079</ix:nonFraction>)</pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Note" contextRef="From20220101To20221231" escape="true">-</ix:nonNumeric></pre></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">益安生醫股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20220101To20221231" escape="true">Medeon International, Inc.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20220101To20221231" escape="true">219</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20220101To20221231" escape="true">薩摩亞</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20220101To20221231" escape="true">投資及貿易業務</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">675,539</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">645,917</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20221231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">22,939,999</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">41,044</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">147,043</ix:nonFraction>)</pre></td> 
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">147,043</ix:nonFraction>)</pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Note" contextRef="From20220101To20221231" escape="true">-</ix:nonNumeric></pre></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">Medeon International, Inc.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20220101To20221231" escape="true">Panther Orthopedics, Inc.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20220101To20221231" escape="true">211</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20220101To20221231" escape="true">美國</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20220101To20221231" escape="true">醫療器材製造及研發</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">166,080</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">166,080</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20221231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">3,833,333</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.00</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">15,857</ix:nonFraction>)</pre></td> 
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">10,791</ix:nonFraction>)</pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Note" contextRef="From20220101To20221231" escape="true">註1及6</ix:nonNumeric></pre></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">Medeon International, Inc.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20220101To20221231" escape="true">Aquedeon Medical, Inc.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20220101To20221231" escape="true">211</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20220101To20221231" escape="true">美國</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20220101To20221231" escape="true">醫療器材製造及研發</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">375,341</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">375,341</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20221231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">6,800,000</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">97.14</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,098</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">118,267</ix:nonFraction>)</pre></td> 
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">114,885</ix:nonFraction>)</pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Note" contextRef="From20220101To20221231" escape="true">註2及3</ix:nonNumeric></pre></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">意能生技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20220101To20221231" escape="true">Prodeon Medical, Inc.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20220101To20221231" escape="true">211</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20220101To20221231" escape="true">美國</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20220101To20221231" escape="true">醫療器材製造及研發</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">84,270</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">84,270</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20221231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">3,000</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">67,284</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">26,511</ix:nonFraction>)</pre></td> 
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">26,511</ix:nonFraction>)</pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Note" contextRef="From20220101To20221231" escape="true">-</ix:nonNumeric></pre></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">益興生醫股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20220101To20221231" escape="true">MediBalloon, Inc.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20220101To20221231" escape="true">211</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20220101To20221231" escape="true">美國</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20220101To20221231" escape="true">醫療器材製造及銷售</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">141,059</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">83,159</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20221231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">13,500,000</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">101,491</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">48,272</ix:nonFraction>)</pre></td> 
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">48,272</ix:nonFraction>)</pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Note" contextRef="From20220101To20221231" escape="true">註5</ix:nonNumeric></pre></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">益興生醫股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20220101To20221231" escape="true">MedeonBio, Inc.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20220101To20221231" escape="true">211</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20220101To20221231" escape="true">美國</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20220101To20221231" escape="true">醫療器材製造及研發</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">99,509</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20221231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">2,900,000</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">71,101</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">18,345</ix:nonFraction>)</pre></td> 
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">18,345</ix:nonFraction>)</pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Note" contextRef="From20220101To20221231" escape="true">-</ix:nonNumeric></pre></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20220101To20221231" escape="true">益興生醫股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20220101To20221231" escape="true">Second Source Medical, LLC</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20220101To20221231" escape="true">211</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20220101To20221231" escape="true">美國</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20220101To20221231" escape="true">醫療器材製造及銷售</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">227,847</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20221231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">184,725</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">48,709</ix:nonFraction>)</pre></td> 
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">48,709</ix:nonFraction>)</pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Note" contextRef="From20220101To20221231" escape="true">-</ix:nonNumeric></pre></td> 
						</ix:tuple>
					</tr>
					<tr>
					<th style="text-align:left" colspan='1'>備註</th> 
						<td colspan='18' style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:Note-NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence" contextRef="From20220101To20221231" escape="true">註1：原始幣別為美金5,999,999元。
註2：原始幣別為美金13,560,000元。
註3：特別股。
註4：含特別股8,615,000股。
註5：含特別股2,500,000股。
註6：Panther Orthopedics, Inc. 於民國111年12月辦理解散清算，其無形資產由Medeon International, Inc. 繼受。</ix:nonNumeric></pre></td> 
					</tr>
				</table>
			<br />
			<div id="InvestmentInMainlandChina"></div>
			<div style="text-align:center">大陸地區投資</div>
			<div style="text-align:center">轉投資大陸地區之事業相關資訊</div>
			<div style="text-align:center">無此情形／免揭露</div>
			<div style="text-align:center">轉投資大陸地區限額</div>
			<div style="text-align:center">無此情形／免揭露</div>
			<br />
			<div id="NonoperatingIncomeAndExpenses"></div>
			<div class="title">營業外收入及支出</div>
			<div class="rptidx">單位：新臺幣仟元</div>
				<table style="width:90%">
					<tr>
						<th style="text-align:left" colspan="4">　 利息收入</th>
					</tr>
					<tr>
						<th style="text-align:center">代號</th>
						<th style="text-align:center">會計項目</th>
						<th style="text-align:center">2022年1月1日至12月31日</th>
						<th style="text-align:center">2021年1月1日至12月31日</th>
					</tr>
					<tr>
						<td>N7101</td>
						<td>　　 銀行存款利息</td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-notes:InterestIncomeFromBankDeposits_n" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">10,288</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-notes:InterestIncomeFromBankDeposits_n" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">6,117</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<td>N7100</td>
						<td>　　 利息收入合計</td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-notes:InterestIncome_n" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">10,288</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-notes:InterestIncome_n" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">6,117</ix:nonFraction> </pre></td>
					</tr>
				</table>
			<br />
			<div id="NonoperatingIncomeAndExpenses"></div>
			<div style="text-align:center">其他收入</div>
			<div style="text-align:center">無此情形／免揭露</div>
			<br />
				<br /> 
				<table style="width:90%"> 
					<tr> 
						<th style="text-align:left" colspan="4">　 其他利益及損失</th> 
					</tr> 
					<tr> 
						<th style="text-align:center">代號</th> 
						<th style="text-align:center">會計項目</th> 
						<th style="text-align:center">2022年1月1日至12月31日</th> 
						<th style="text-align:center">2021年1月1日至12月31日</th> 
					</tr>					<tr>
						<td>N7225</td>
						<td>　　 處分投資利益(損失)</td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-notes:GainsLossesOnDisposalsOfInvestments_n" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">20,412</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-notes:GainsLossesOnDisposalsOfInvestments_n" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">55,078</ix:nonFraction>)</pre></td>
					</tr>
					<tr>
						<td>N7230</td>
						<td>　　 外幣兌換利益(損失)</td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-notes:ForeignExchangeGainsLosses_n" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">15,351</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-notes:ForeignExchangeGainsLosses_n" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">4,030</ix:nonFraction>)</pre></td>
					</tr>
					<tr>
						<td>N7235</td>
						<td>　　 透過損益按公允價值衡量之金融資產(負債)利益(損失)</td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-notes:GainsLossesOnFinancialAssetsOrLiabilitiesAtFairValueThroughProfitOrLoss_n" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">681</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-notes:GainsLossesOnFinancialAssetsOrLiabilitiesAtFairValueThroughProfitOrLoss_n" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,479</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<td>N7600</td>
						<td>　　 其他利益及損失</td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-notes:OtherGainsAndLossesOthers_n" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">336</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-notes:OtherGainsAndLossesOthers_n" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">13,557</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<td>N7020</td>
						<td>　　 其他利益及損失淨額</td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-notes:OtherGainsAndLosses_n" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">4,044</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-notes:OtherGainsAndLosses_n" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">43,072</ix:nonFraction>)</pre></td>
					</tr>
				</table>
			<br />
				<br /> 
				<table style="width:90%"> 
					<tr> 
						<th style="text-align:left" colspan="4">　 財務成本</th> 
					</tr> 
					<tr> 
						<th style="text-align:center">代號</th>
						<th style="text-align:center">會計項目</th> 
						<th style="text-align:center">2022年1月1日至12月31日</th> 
						<th style="text-align:center">2021年1月1日至12月31日</th> 
					</tr> 
					<tr>
						<td>N7510</td>
						<td>　　 利息費用</td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-notes:InterestExpense_n" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">5,211</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-notes:InterestExpense_n" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,027</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<td>N7050</td>
						<td>　　 財務成本淨額</td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-notes:FinanceCosts_n" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">5,211</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-notes:FinanceCosts_n" contextRef="From20210101To20211231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,027</ix:nonFraction> </pre></td>
					</tr>
				</table>
			<br /> 
			</span>
		</div> 
		<br /> 
	</div> 
</body> 
</html> 

<!--This instance document is created by SIIAP V2.4.9-->

